James D. Cox - Publications

Affiliations: 
1969 Radiation Oncology Penrose Cancer Hospital 
 1988-2012 Radiation Oncology MD Anderson Cancer Center, Houston, TX, United States 
Area:
Radiotherapy, Proton radiotherapy
Website:
https://www3.mdanderson.org/library/hrc/legacies/cox.html

461 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Suzuki R, Wei X, Allen PK, Cox JD, Komaki R, Lin SH. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer. Clinical Lung Cancer. PMID 30611672 DOI: 10.1016/J.Cllc.2018.11.013  0.439
2018 Suzuki R, Wei X, Allen PK, Welsh JW, Cox JD, Komaki R, Lin SH. Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis. Radiation Oncology (London, England). 13: 258. PMID 30594213 DOI: 10.1186/S13014-018-1205-9  0.399
2018 Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, et al. Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. Advances in Radiation Oncology. 3: 405-411. PMID 30202809 DOI: 10.1016/J.Adro.2018.04.010  0.359
2018 Suzuki R, Wei X, Allen PK, Welsh JW, Cox JD, Komaki R, Lin SH. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis. Clinical Lung Cancer. PMID 30197263 DOI: 10.1016/J.Cllc.2018.08.012  0.487
2018 Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, et al. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017740720. PMID 29293386 DOI: 10.1200/Jco.2017.74.0720  0.521
2018 Kono M, Allen P, Lin S, Wei X, Jeter M, Welsh J, Cox J, Komaki R. Incidence and Survival of Patients who Developed Limited-Stage Small Cell Lung Cancer after Successful Treatment of a Previous Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e724. DOI: 10.1016/J.IJROBP.2018.07.1942  0.341
2017 Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, et al. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. International Journal of Radiation Oncology, Biology, Physics. 99: 667-676. PMID 29280461 DOI: 10.1016/J.Ijrobp.2017.06.2450  0.428
2017 Shi A, Liao Z, Allen PK, Ho L, Murphy MB, Maru DM, Swisher SG, Hofstetter WL, Mehran RJ, Cox JD, Komaki R, Lin SH. Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study. Advances in Radiation Oncology. 2: 316-324. PMID 29114598 DOI: 10.1016/J.Adro.2017.04.002  0.495
2017 Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh J, Cox JD, Crane CH, Hsu CC, Lin SH. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 99: 128-135. PMID 28816138 DOI: 10.1016/J.Ijrobp.2017.05.037  0.403
2017 Kono M, Allen PK, Lin SH, Wei X, Jeter M, Welsh JW, Cox JD, Komaki R. Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28804012 DOI: 10.1016/J.Jtho.2017.07.030  0.449
2017 Chang JY, Verma V, Li M, Zhang W, Komaki R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, Gomez D, Jeter M, O'Reilly M, Zhu RX, Zhang X, ... ... Cox JD, et al. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer: Final Results of a Phase 2 Study. Jama Oncology. e172032. PMID 28727865 DOI: 10.1001/Jamaoncol.2017.2032  0.441
2017 Lin SH, Merrell KW, Shen J, Verma V, Correa AM, Wang L, Thall PF, Bhooshan N, James SE, Haddock MG, Suntharalingam M, Mehta MP, Liao Z, Cox JD, Komaki R, et al. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28455153 DOI: 10.1016/J.Radonc.2017.04.013  0.415
2017 Chang JY, Zhang W, Komaki R, Choi NC, Chan S, Gomez D, O'Reilly M, Jeter M, Gillin M, Zhu X, Zhang X, Mohan R, Swisher S, Hahn S, Cox JD. Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28139305 DOI: 10.1016/J.Radonc.2016.10.022  0.437
2017 Farooqi AS, Holliday EB, Allen PK, Wei X, Cox JD, Komaki R. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit? Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28073578 DOI: 10.1016/J.Radonc.2016.11.012  0.501
2017 Nguyen Q, Blanchard P, Komaki R, Jeter M, Gomez D, Lu C, Zhu X, Gillin M, Ho J, Chang J, Hahn S, Cox J, Liao Z. Reported Outcomes and Toxicities for Inoperable, Stage II-III Non–Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity Modulated Proton Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E484-E485. DOI: 10.1016/J.Ijrobp.2017.06.1761  0.365
2017 Elhammali A, Colbert LE, Komaki RU, Lee JJ, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR, Heymach J, Allen PK, Hahn SM, Cox JD, Lu C, Mohan R, Liao Z. Diffusion Capacity of the Lungs Following Passive-Scattering Proton Therapy and Intensity-Modulated Photon Radiation Therapy for Locally Advanced Non–small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1689  0.334
2016 Jiang W, Davuluri R, Fang P, Xu C, Welsh JW, Crane CH, Komaki RU, Cox JD, Hsu CC, Lin SH. Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response. International Journal of Radiation Oncology, Biology, Physics. 96: S151. PMID 27675652 DOI: 10.1016/J.Ijrobp.2016.06.366  0.361
2016 Komaki RU, Allen PK, Wei X, Welsh JW, Lin SH, Cox JD. Completing Thoracic Radiation Therapy With Concurrent Chemotherapy Within 6 weeks Is Important for Reducing Distant Disease in Patients With Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E466-E467. PMID 27674767 DOI: 10.1016/J.Ijrobp.2016.06.1801  0.518
2016 Wei X, Allen PK, Welsh JW, Lin SH, Cox JD, Komaki RU. Immediately Concurrent Chemoradiation Therapy Is Associated With Improved 2-Year Overall Survival in Patients With Limited Small-Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E454-E455. PMID 27674735 DOI: 10.1016/J.Ijrobp.2016.06.1771  0.477
2016 Kono M, Allen PK, Lin SH, Wei X, Jeter MD, Welsh JW, Cox JD, Komaki RU. Incidence of and Survival Outcomes After Metachronous Second Primary Malignancy After the Treatment of Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E430. PMID 27674672 DOI: 10.1016/J.Ijrobp.2016.06.1711  0.43
2016 Davuluri R, Jiang W, Fang P, Xu C, Komaki RU, Hsu CC, Lin SH, Welsh JW, Cox JD, Crane CH. Absolute Lymphocyte Count Nadir During Chemoradiation as a Prognostic Indicator of Esophageal Cancer Survival Outcomes. International Journal of Radiation Oncology, Biology, Physics. 96: E177. PMID 27673979 DOI: 10.1016/J.Ijrobp.2016.06.1035  0.359
2016 Wang XS, Shi Q, Williams LA, Komaki R, Gomez DR, Lin SH, Chang JY, O'Reilly MS, Bokhari RH, Cox JD, Mohan R, Cleeland CS, Liao Z. Prospective Study of Patient-Reported Symptom Burden in Patients with Non-Small Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy. Journal of Pain and Symptom Management. PMID 26891607 DOI: 10.1016/J.Jpainsymman.2015.12.316  0.495
2016 Liao ZX, Lee JJ, Komaki R, Gomez DR, O'Reilly M, Allen P, Fossella FV, Heymach J, Blumenschein GR, Choi NC, Delaney T, Hahn SM, Lu C, Cox JD, Mohan R. Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer. Journal of Clinical Oncology. 34: 8500-8500. DOI: 10.1200/Jco.2016.34.15_Suppl.8500  0.516
2016 Howard K, Austin S, Ramirez A, Ritter L, Boles D, Pruitt J, Collins H, Mahen E, Leonti A, Maassel L, Subia C, Tuuli S, Heying N, Deutsch K, Cox J, et al. Abstract P2-02-21: Longitudinal analysis of circulating tumor cells and cell free tumor DNA by next generation sequencing in triple negative breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-02-21  0.345
2015 Nguyen QN, Ly NB, Komaki R, Levy LB, Gomez DR, Chang JY, Allen PK, Mehran RJ, Lu C, Gillin M, Liao Z, Cox JD. Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 115: 367-72. PMID 26028228 DOI: 10.1016/J.Radonc.2015.05.014  0.479
2015 Howard K, Austin S, Ramirez A, Ritter L, Boles D, Cox J, Lo FY, Deutsch K, Subia C, Saloranta T, Heying N, Collins H, Leonti A, Maassel L, Stilwell J, et al. Abstract 1609: Comprehensive multi-omic analysis of circulating tumor cells isolated from a metastatic triple-negative breast cancer patient to identify pathogenic genomic aberrations Cancer Research. 75: 1609-1609. DOI: 10.1158/1538-7445.Am2015-1609  0.305
2015 Tang C, Tucker SL, Zhuang Y, Gomez DR, Komaki RU, Mohan R, Cox JD, Liao Z. Decreased Risk of Radiation Pneumonitis With Proton Beam Therapy in the Definitive Treatment of Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.358  0.457
2015 Komaki RU, Wei X, Allen PK, Holliday E, Farooqi A, Lin SH, Balter P, Mohan R, Liao Z, Cox JD. Factors Associated With Severe Pneumonitis for Limited Stage Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1658  0.394
2015 Wei X, Allen PK, Erasmus J, Blumenschein GR, Godoy M, Lee JJ, O'Reilly MS, Welsh JW, Cox JD, Hong WK, Komaki RU. PET Metabolic Tumor Response by PERCIST Reliably Predicts Local Regional Control in Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy With Erlotinib International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1574  0.401
2014 Gomez DR, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, Pan HY, Chang JY, Komaki R, Cox JD, McAleer MF, Grosshans DR. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1554-60. PMID 25521400 DOI: 10.1097/Jto.0000000000000306  0.396
2014 Kardar L, Li Y, Li X, Li H, Cao W, Chang JY, Liao L, Zhu RX, Sahoo N, Gillin M, Liao Z, Komaki R, Cox JD, Lim G, Zhang X. Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting. Practical Radiation Oncology. 4: e259-68. PMID 25407877 DOI: 10.1016/J.Prro.2014.06.010  0.393
2014 McAvoy S, Ciura K, Wei C, Rineer J, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes. International Journal of Radiation Oncology, Biology, Physics. 90: 819-27. PMID 25220718 DOI: 10.1016/J.Ijrobp.2014.07.030  0.526
2014 Zhu Z, Liu W, Gillin M, Gomez DR, Komaki R, Cox JD, Mohan R, Chang JY. Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial. Radiation Oncology (London, England). 9: 108. PMID 24886059 DOI: 10.1186/1748-717X-9-108  0.446
2014 Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, et al. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. International Journal of Radiation Oncology, Biology, Physics. 89: 846-53. PMID 24867532 DOI: 10.1016/J.Ijrobp.2014.04.019  0.432
2014 Li Y, Kardar L, Li X, Li H, Cao W, Chang JY, Liao L, Zhu RX, Sahoo N, Gillin M, Liao Z, Komaki R, Cox JD, Lim G, Zhang X. On the interplay effects with proton scanning beams in stage III lung cancer. Medical Physics. 41: 021721. PMID 24506612 DOI: 10.1118/1.4862076  0.398
2014 Wang J, Myles B, Wei C, Chang JY, Hofstetter WL, Ajani JA, Swisher SG, Cox JD, Komaki R, Liao Z, Lin SH. Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 27: 168-75. PMID 23621168 DOI: 10.1111/Dote.12074  0.372
2014 Gomez DR, Gladish GW, Wei X, Kotamarti KR, Allen PK, Cox JD, O'Reilly MS, Erasmus JJ, Fossella FV, Komaki R. Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy. American Journal of Clinical Oncology. 37: 77-80. PMID 23111360 DOI: 10.1097/Coc.0B013E31826B9Cb8  0.42
2014 Wei X, Allen P, Liao Z, Skinner H, Welsh J, Gomez D, Nguyen Q, Lin S, Heymach J, Cox J, Komaki R. Nadir White Blood Cell, Absolute Neutrophil, and Absolute Lymphocyte Counts During Concurrent Chemoradiation Therapy Are Associated With Worse Outcomes in Patients With Limited-Stage Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S66-S67. DOI: 10.1016/J.Ijrobp.2014.08.293  0.434
2014 Nguyen Q, Komaki R, Liao Z, Ly N, Levy L, Gomez D, Chang J, Cox JD. Poster PresentationThe 5-Year Outcome for Patients Diagnosed With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Concurrent Chemotherapy and Proton Beam Therapy: Locally Advanced Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.171  0.476
2014 Liao Z, Mohan R, Xu T, Cox JD, Tucker SL. Poster PresentationComparing Risk of Radiation Pneumonitis After Intensity Modulated Radiation Therapy Versus Proton Therapy: Locally Advanced Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.169  0.468
2014 Pan H, Grosshans DR, Yusuf SW, Munsell M, Welsh JW, Liao Z, Lin SH, Chang JY, Komaki RU, Cox JD, McAleer MF, Gomez DR. A Prospective Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy With High-Dose Heart Exposure International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1873  0.379
2014 Wei X, Allen P, Liao Z, Skinner H, Welsh J, Gomez D, Nguyen Q, Lin S, Heymach J, Cox J, Komaki R. Nadir White Blood Cell, Absolute Neutrophil, and Absolute Lymphocyte Counts During Concurrent Chemoradiation Therapy Are Associated With Worse Outcomes in Patients With Limited-Stage Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S623. DOI: 10.1016/J.Ijrobp.2014.05.1856  0.434
2014 Komaki R, Allen P, Wei X, Liao Z, Skinner H, Welsh J, Gomez D, Nguyen Q, Lin S, Heymach J, Cox J. Predictors of Brain Metastasis After Prophylactic Cranial Irradiation for Limited-Stage Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S622-S623. DOI: 10.1016/J.Ijrobp.2014.05.1854  0.411
2014 Nguyen Q, Komaki R, Liao Z, Ly N, Levy L, Gomez D, Chang J, Cox JD. The 5-Year Outcome for Patients Diagnosed With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Concurrent Chemotherapy and Proton Beam Therapy International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1846  0.424
2014 Thaker NG, Komaki R, Golden DW, Boehling NS, Gunther JR, Hillebrandt E, Mahajan A, Cox JD, Frank SJ, Woodward WA, Das P. Improving the Quality of Radiation Oncology Education Through an Innovative Medical Student Treatment Planning Curriculum International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1800  0.554
2014 Liao Z, Mohan R, Xu T, Cox JD, Tucker SL. Comparing Risk Of Radiation Pneumonitis After Intensity-modulated Radiotherapy Vs. Proton Therapy International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.163  0.387
2014 Skinner HD, Komaki RU, Chang JY, Cox JD. Individualized Radiotherapy by Dose Escalation and Altered Fractionation in Non-Small Cell Lung Cancer Lung Cancer: Fourth Edition. 379-389. DOI: 10.1002/9781118468791.ch24  0.341
2013 Yang J, Amini A, Williamson R, Zhang L, Zhang Y, Komaki R, Liao Z, Cox J, Welsh J, Court L, Dong L. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy. Practical Radiation Oncology. 3: e139-47. PMID 24674411 DOI: 10.1016/J.Prro.2013.01.002  0.438
2013 Welsh J, Amini A, Ciura K, Nguyen N, Palmer M, Soh H, Allen PK, Paolini M, Liao Z, Bluett J, Mohan R, Gomez D, Cox JD, Komaki R, Chang JY. Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 38: 442-7. PMID 24200220 DOI: 10.1016/J.Meddos.2013.08.001  0.457
2013 McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109: 38-44. PMID 24016675 DOI: 10.1016/J.Radonc.2013.08.014  0.515
2013 Shirvani SM, Juloori A, Allen PK, Komaki R, Liao Z, Gomez D, O'Reilly M, Welsh J, Papadimitrakopoulou V, Cox JD, Chang JY. Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 87: 139-47. PMID 23920393 DOI: 10.1016/J.Ijrobp.2013.05.040  0.527
2013 Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH. Predictors of postoperative complications after trimodality therapy for esophageal cancer. International Journal of Radiation Oncology, Biology, Physics. 86: 885-91. PMID 23845841 DOI: 10.1016/J.Ijrobp.2013.04.006  0.373
2013 Yuan X, Wei Q, Komaki R, Liu Z, Yang J, Tucker SL, Xu T, Heymach JV, Lu C, Cox JD, Liao Z. TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy. Plos One. 8: e65659. PMID 23840350 DOI: 10.1371/Journal.Pone.0065659  0.392
2013 Gomez DR, Gillin M, Liao Z, Wei C, Lin SH, Swanick C, Alvarado T, Komaki R, Cox JD, Chang JY. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 86: 665-70. PMID 23688815 DOI: 10.1016/J.Ijrobp.2013.03.035  0.513
2013 Evans JD, Gomez DR, Amini A, Rebueno N, Allen PK, Martel MK, Rineer JM, Ang KK, McAvoy S, Cox JD, Komaki R, Welsh JW. Aortic dose constraints when reirradiating thoracic tumors. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 106: 327-32. PMID 23453540 DOI: 10.1016/J.Radonc.2013.02.002  0.401
2013 Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 67-74. PMID 23002278 DOI: 10.1093/Annonc/Mds274  0.451
2013 Skinner HD, McCurdy MR, Echeverria AE, Lin SH, Welsh JW, O'Reilly MS, Hofstetter WL, Ajani JA, Komaki R, Cox JD, Sandulache VC, Myers JN, Guerrero TM. Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncologica (Stockholm, Sweden). 52: 1002-9. PMID 22950385 DOI: 10.3109/0284186X.2012.718096  0.367
2013 Wang XS, Liao ZX, Komaki R, Cox JD, Gomez DR, Bokhari RH, Sailors ML, Cleeland CS. Patient-reported symptom burdens in NSCLC patients undergoing proton, 3DCRT, or IMRT. Journal of Clinical Oncology. 31: 7574-7574. DOI: 10.1200/Jco.2013.31.15_Suppl.7574  0.449
2013 Nguyen Q, Komaki R, Liao Z, Allen P, Gomez D, Chang JY, Crawford C, Lu C, Tsao A, Cox JD. Risk Factors Predicting Failure and Survival in Lung Cancer Patients Treated With Definitive Dose-Escalated Proton Radiation Therapy International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.203  0.497
2013 Komaki RU, Allen P, Wei X, Gomez D, Kotamarti KR, Heymach J, Welsh J, O'Reilly M, Lin S, Cox J. Duration of Thoracic Radiation Therapy With Concurrent Chemotherapy Is Important for the Outcome of Patients With Limited-Stage Small Cell Lung Cancer (L-SCLC) International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1420  0.494
2013 Wei X, Allen PK, Gomez D, Kotamarti K, Heymach J, Welsh J, O'Reilly MS, Lin SH, Cox JD, Komaki R. Improved 5-Year Disease Free-Survival and Distant Metastasis-Free Survival for Patients With Limited-Stage Small Cell Lung Cancer Who Had 18F-fluorodeoxyglucose Positron Emission Tomography (PET) or PET/CT Before Chemoradiation Therapy International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1418  0.388
2012 Myles BH, Wei C, Komaki R, Vaporciyan AA, Mehran RJ, Swisher S, Hofstetter WL, Ajani JA, Liao ZX, Cox JD, Lin SH. Effect of technologic advancements in radiotherapy on postoperative pulmonary complications after neoadjuvant chemoradiation in esophageal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 110. PMID 27983086 DOI: 10.1200/jco.2012.30.4_suppl.110  0.317
2012 Lin SH, Myles BH, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher S, Lee JH, Bhutani MS, Maru D, Ajani JA, Cox JD, Komaki R, Liao ZX. Propensity score-based comparison of outcomes with 3D conformal radiotherapy (3D-CRT) versus intensity-modulated radiation therapy (IMRT) in treatment of esophageal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 66. PMID 27982879 DOI: 10.1200/Jco.2012.30.4_Suppl.66  0.307
2012 Grosshans D, Boehling NS, Palmer M, Spicer C, Erice R, Cox JD, Komaki R, Chang JY. Improving cardiac dosimetry: Alternative beam arrangements for intensity modulated radiation therapy planning in patients with carcinoma of the distal esophagus. Practical Radiation Oncology. 2: 41-5. PMID 24674035 DOI: 10.1016/J.Prro.2011.04.007  0.387
2012 Xiang ZL, Erasmus J, Komaki R, Cox JD, Chang JY. FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy. Radiation Oncology (London, England). 7: 144. PMID 22929048 DOI: 10.1186/1748-717X-7-144  0.452
2012 Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, Liu H, Komaki R, Cox JD, Liao Z. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 84: 1010-6. PMID 22920974 DOI: 10.1016/J.Ijrobp.2012.01.071  0.494
2012 Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. International Journal of Radiation Oncology, Biology, Physics. 84: 1078-85. PMID 22867894 DOI: 10.1016/J.Ijrobp.2012.02.015  0.412
2012 Lopez Guerra JL, Gomez D, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 83: 1573-9. PMID 22768989 DOI: 10.1016/J.Ijrobp.2011.10.065  0.495
2012 Tucker SL, Michalski JM, Bosch WR, Mohan R, Dong L, Winter K, Purdy JA, Cox JD. Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 104: 109-13. PMID 22673726 DOI: 10.1016/J.Radonc.2012.04.023  0.422
2012 Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, Parliament M, Purdy JA, Valicenti RK, Cox JD. Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406. International Journal of Radiation Oncology, Biology, Physics. 83: e363-70. PMID 22633552 DOI: 10.1016/J.Ijrobp.2011.12.070  0.462
2012 Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 84: 1093-100. PMID 22543217 DOI: 10.1016/J.Ijrobp.2012.02.041  0.493
2012 Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. International Journal of Radiation Oncology, Biology, Physics. 84: e61-7. PMID 22503522 DOI: 10.1016/J.Ijrobp.2012.02.054  0.498
2012 Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G. Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer International Journal of Radiation Oncology Biology Physics. 83: e273-e280. PMID 22440040 DOI: 10.1016/J.Ijrobp.2011.12.048  0.45
2012 Lopez Guerra JL, Gomez DR, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 83: e537-43. PMID 22420964 DOI: 10.1016/J.Ijrobp.2012.01.019  0.499
2012 Amini A, Lin SH, Wei C, Allen P, Cox JD, Komaki R. Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer. Radiation Oncology (London, England). 7: 33. PMID 22420631 DOI: 10.1186/1748-717X-7-33  0.507
2012 Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton beam therapy and concurrent chemotherapy for esophageal cancer. International Journal of Radiation Oncology, Biology, Physics. 83: e345-51. PMID 22417808 DOI: 10.1016/J.Ijrobp.2012.01.003  0.405
2012 Tucker SL, Dong L, Michalski JM, Bosch WR, Winter K, Cox JD, Purdy JA, Mohan R. Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06. International Journal of Radiation Oncology, Biology, Physics. 84: 390-5. PMID 22342302 DOI: 10.1016/J.Ijrobp.2011.11.073  0.414
2012 Amini A, Yang J, Williamson R, McBurney ML, Erasmus J, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J, Dong L, Welsh J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. International Journal of Radiation Oncology, Biology, Physics. 82: e391-8. PMID 22284035 DOI: 10.1016/J.Ijrobp.2011.06.1961  0.46
2012 Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. International Journal of Radiation Oncology, Biology, Physics. 83: 332-9. PMID 22079735 DOI: 10.1016/J.Ijrobp.2011.06.1963  0.506
2012 Gomez DR, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R. A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer. 118: 444-51. PMID 21713767 DOI: 10.1002/Cncr.26277  0.415
2012 Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal cancer dose escalation using a simultaneous integrated boost technique. International Journal of Radiation Oncology, Biology, Physics. 82: 468-74. PMID 21123005 DOI: 10.1016/J.Ijrobp.2010.10.023  0.458
2012 Lin SH, Wang L, Myles BH, Thall PF, Hofstetter WL, Swisher S, Lee JE, Bhutani MS, Maru DM, Ajani JA, Ho L, Cox JD, Komaki R, Liao ZX. Inverse-probability weighted and propensity score-based analysis of long-term clinical outcomes comparing 3D conformal radiotherapy (3DCRT) with intensity-modulated radiation therapy (IMRT) in the treatment of esophageal cancer. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E14548  0.417
2012 Gomez DR, Guerra JLL, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Oc-0499 Prognostic Impact Of Radiation Therapy To The Primary Tumor In Patients With Oligometastatic Lung Cancer Radiotherapy and Oncology. 103. DOI: 10.1016/S0167-8140(12)70838-1  0.487
2012 Guerra JLL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Swisher SG, Cox JD, Liao Z, Rice C. Oc-0496 Risk Factors For Local And Regional Recurrence In Patients With Resected N0-N1 Non-Small Cell Lung Cancer Radiotherapy and Oncology. 103. DOI: 10.1016/S0167-8140(12)70835-6  0.386
2012 McAvoy SA, Komaki R, Allen P, Rineer J, Liao Z, Chang J, Welsh J, Palmer M, Cox J, Gomez D. Reirradiation With Proton Beam Therapy or Intensity Modulated Radiation Therapy for Non-small Cell Lung Cancer: An Institutional Experience International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1622  0.446
2012 Grant J, Gomez D, Zhuang Y, Chang J, Komaki R, Fossella F, Gold K, Liao Z, Cox J. Impact of Chemotherapy Response and Radiation Dose on Overall Survival in Patients With Inoperable Non-small Cell Lung Cancer Treated With Induction Chemotherapy Followed by Concurrent Chemoradiation Therapy International Journal of Radiation Oncology*Biology*Physics. 84: S593. DOI: 10.1016/J.Ijrobp.2012.07.1581  0.532
2012 Liao Z, Tucker SL, Gomez D, Grosshans DR, Zhuang Y, Krafft SP, Martel MK, Mohan R, Komaki R, Cox JD. Heart and Lung Radiation and Overall Survival in Non-small Cell Lung Cancer Patients After Chemoradiation Therapy International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1541  0.489
2012 Mohan R, Matney JE, Bluett J, Palmer M, Choi N, Chang J, Komaki R, Cox J, Liao Z. IMRT Versus Passively Scattered Proton Therapy (PSPT) for Locally Advanced NSCLC -- Impact of Changing Techniques and Technologies Over the Course of a Randomized Trial International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1506  0.324
2012 Frank SJ, Cox JD, Gillin M, Rosenthal DI, Garden AS, Ang K, Mohan R, Palmer MB, Amin M, Zhu XR. Intensity Modulated Proton Therapy for Head-and-Neck Cancer: The First Clinical Experience International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1260  0.341
2012 Wang J, Wei C, Myles B, Cox JD, Komaki R, Liao Z, Lin SH. Radiation Modality is a Strong Predictor for Postoperative Pulmonary and GI Complications After Trimodality Therapy for Esophageal Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.110  0.411
2011 Chang JY, Komaki R, Lu C, When HY, Allen P, Tsao AS, Gillin M, Mohan R, Cox JD. Phase II study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III non-small cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7017. PMID 28020081 DOI: 10.1200/jco.2011.29.15_suppl.7017  0.431
2011 Komaki R, Wei X, Allen PK, Liao Z, Milas L, Cox JD, O'Reilly MS, Chang JY, McAleer MF, Jeter M, Blumenschein GR, Kies MS. Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer. Frontiers in Oncology. 1: 52. PMID 22649768 DOI: 10.3389/Fonc.2011.00052  0.514
2011 Lopez Guerra JL, Wei Q, Yuan X, Gomez D, Liu Z, Zhuang Y, Yin M, Li M, Wang LE, Cox JD, Liao Z. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 101: 271-7. PMID 21937138 DOI: 10.1016/J.Radonc.2011.08.039  0.433
2011 Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. Journal of the National Cancer Institute. 103: 1452-60. PMID 21903745 DOI: 10.1093/Jnci/Djr325  0.477
2011 Liao Z, Lin SH, Cox JD. Status of particle therapy for lung cancer. Acta Oncologica (Stockholm, Sweden). 50: 745-56. PMID 21767170 DOI: 10.3109/0284186X.2011.590148  0.509
2011 Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. International Journal of Radiation Oncology, Biology, Physics. 81: 1336-42. PMID 21470796 DOI: 10.1016/J.Ijrobp.2010.07.2001  0.442
2011 Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 117: 4707-13. PMID 21437893 DOI: 10.1002/cncr.26080  0.508
2011 Valicenti RK, Bae K, Michalski J, Sandler H, Shipley W, Lin A, Cox J. Does Hormone Therapy Reduce Disease Recurrence in Prostate Cancer Patients Receiving Dose-Escalated Radiation Therapy? An Analysis of Radiation Therapy Oncology Group 94-06 International Journal of Radiation Oncology Biology Physics. 79: 1323-1329. PMID 21414514 DOI: 10.1016/J.Ijrobp.2010.01.009  0.44
2011 Tucker SL, Thames HD, Michalski JM, Bosch WR, Mohan R, Winter K, Cox JD, Purdy JA, Dong L. Estimation of α/β for late rectal toxicity based on RTOG 94-06. International Journal of Radiation Oncology, Biology, Physics. 81: 600-5. PMID 21377288 DOI: 10.1016/J.Ijrobp.2010.11.080  0.328
2011 Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M, Cox JD. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer. 117: 3004-13. PMID 21264827 DOI: 10.1002/Cncr.25848  0.523
2011 Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 80: 1350-7. PMID 21251767 DOI: 10.1016/J.Ijrobp.2010.04.049  0.439
2011 Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, Garcia JA, Cox JD. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. International Journal of Radiation Oncology, Biology, Physics. 81: 167-74. PMID 20643518 DOI: 10.1016/J.Ijrobp.2010.05.007  0.572
2011 Myles BA, Lin SH, Tucker SL, Ajani JA, Hofstetter WL, Swisher SG, Ho L, Komaki R, Cox JD, Liao Z. Long Term Outcomes Comparing Three-dimensional Conformal Radiation Therapy to Intensity Modulated Radiation Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancer: The MD Anderson Experience International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.262  0.428
2011 Ciura KT, Welsh J, Nguyen N, Palmer M, Paolini M, Bluett J, Mohan R, Gomez D, Cox JD, Chang J. Evaluating Stereotactic Body Radiotherapy with Protons to Reduce Chest Wall Dose in the Treatment of Lung Cancer International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.177  0.429
2011 Gomez DR, Amin MV, Crawford C, Welsh J, Chang JY, Zhu XR, Liao Z, Komaki RU, Cox JD, Mohan R. A Comparison Of Strategies To Account For Bowel Filling In Patients Treated With Proton Therapy For Locally Advanced Distal Esophageal Cancer: A Planning Study International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1579  0.428
2011 Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G. Interfractional Reproducibility of Gastro-Esophageal Junction (GEJ) Location for Patients with Esophageal Cancer International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1213  0.357
2011 Fang L, Chang JY, Komaki R, Liao Z, Kim E, Allen P, Lu C, Tsao A, Gillin M, Cox JD. Failure Patterns and Toxicity After Chemoradiation with 74 Gy(RBE) for Non-small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1130  0.405
2011 Wei X, Allen PK, O'Reilly MS, Fossella FV, Liao ZX, Heymach J, Herbst RS, Chang JY, Cox JD, Komaki R. Predictive Factors Of Long-term Five Years Overall Survival Among Patients With Limited Small Cell Lung Cancer Treated With Radiation Treatment And Chemotherapy By Treatment Time Periods International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1102  0.469
2011 Koay E, Lege D, Palmer M, Komaki R, Cox J, Chang J. An Analysis of Adaptive Proton Planning in a Phase II Trial For Locally Advanced Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S580. DOI: 10.1016/J.Ijrobp.2011.06.1085  0.397
2011 Xiang Z, Wen H, Jeremy E, O'Reilly M, Komaki R, Cox JD, Chang JY. FDG Uptake Predicts Recurrence and Survival in Patients with Unresectable Stage III Non-small Cell Lung Cancer Treated with 74 Gy (RBE) Proton Therapy and Chemotherapy International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.105  0.501
2010 Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Plos One. 5: e12402. PMID 20811626 DOI: 10.1371/Journal.Pone.0012402  0.344
2010 Chang JY, Cox JD. Improving radiation conformality in the treatment of non-small cell lung cancer. Seminars in Radiation Oncology. 20: 171-7. PMID 20652085 DOI: 10.1016/J.Semradonc.2010.01.005  0.441
2010 Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD. Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model. International Journal of Radiation Oncology, Biology, Physics. 78: 1253-60. PMID 20598811 DOI: 10.1016/J.Ijrobp.2010.01.069  0.42
2010 Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, Liu HH, Mohan R, Chen Y, Cox JD, Liao Z. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 77: 691-8. PMID 19836159 DOI: 10.1016/J.Ijrobp.2009.05.055  0.473
2010 Zhang X, Li Y, Pan X, Xiaoqiang L, Mohan R, Komaki R, Cox JD, Chang JY. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. International Journal of Radiation Oncology, Biology, Physics. 77: 357-66. PMID 19660879 DOI: 10.1016/J.Ijrobp.2009.04.028  0.48
2010 Michalski JM, Bae K, Roach M, Markoe AM, Sandler HM, Ryu J, Parliament MB, Straube W, Valicenti RK, Cox JD. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. International Journal of Radiation Oncology, Biology, Physics. 76: 14-22. PMID 19577865 DOI: 10.1016/J.Ijrobp.2009.01.062  0.419
2010 McAleer MF, Moughan J, Byhardt RW, Cox JD, Sause WT, Komaki R. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808. International Journal of Radiation Oncology, Biology, Physics. 76: 802-8. PMID 19540055 DOI: 10.1016/J.Ijrobp.2009.02.053  0.478
2010 Liao ZX, Komaki RR, Thames HD, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 76: 775-81. PMID 19515503 DOI: 10.1016/J.Ijrobp.2009.02.032  0.523
2010 Gomez DR, Gladish GW, Wei X, Allen P, Cox JD, O'Reilly M, Erasmus JJ, Fossella FV, Komaki R. Pretreatment positron emission tomography (PET) scan standardized uptake value (SUV) as a prognostic variable for overall survival in limited-stage small cell lung cancer (L-SCLC). Journal of Clinical Oncology. 28: 7045-7045. DOI: 10.1200/Jco.2010.28.15_Suppl.7045  0.43
2010 Komaki R, Wei X, Allen P, Roth JA, Swisher S, Rice DC, Walsh GL, Fossella FV, Erasmus JJ, Cox JD. Treatment for superior sulcus tumors (SST): Effect of surgery first followed by adjunct concurrent chemoradiotherapy on survival of patients with marginally resectable SST. Journal of Clinical Oncology. 28: 7026-7026. DOI: 10.1200/Jco.2010.28.15_Suppl.7026  0.352
2010 Gomez DR, Tucker SL, Martel MK, Zhuang Y, Balter PA, Lopez JL, Jiang CZ, Komaki R, Cox JD, Liao Z. Predictive Dosimetric Factors for High-grade Esophagitis in Patients Treated for Non-small Cell Lung Cancer (NSCLC) with Definitive 3D Conformal Therapy (3D-CRT), Intensity Modulated Radiation Therapy (IMRT), or Proton Beam Therapy (PBT) International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.489  0.466
2010 Likhacheva A, Thomas J, Kim E, Allen P, Komaki R, Cox J, Herbst R, Welsh J. Predictive Implications of KRAS and EGFR Gene Mutations in Non-small Cell Lung Cancer Treated with Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 78: S128-S129. DOI: 10.1016/J.Ijrobp.2010.07.323  0.417
2010 Welsh JW, Riley B, Palmer MB, Amin MV, Komaki R, Gomez D, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity Modulated Proton Therapy Allows Dose Escalation and Normal-Tissue Sparing in Locally Advanced Distal Esophageal Tumors International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.1872  0.365
2009 Albain KS, Swann RS, Rusch VW, Turrisi AT, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johnson DH, Green MR, Miller RC, ... ... Cox JD, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 374: 379-86. PMID 19632716 DOI: 10.1016/S0140-6736(09)60737-6  0.458
2009 Arjomandy B, Sahoo N, Cox J, Lee A, Gillin M. Comparison of surface doses from spot scanning and passively scattered proton therapy beams Physics in Medicine and Biology. 54. PMID 19550003 DOI: 10.1088/0031-9155/54/14/N02  0.345
2009 McGovern SL, Liao Z, Bucci MK, McAleer MF, Jeter MD, Chang JY, O'Reilly MS, Cox JD, Allen PK, Komaki R. Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? Cancer. 115: 3233-42. PMID 19472405 DOI: 10.1002/Cncr.24361  0.344
2009 Schechter NR, Erwin WD, Yang DJ, Kim EE, Munden RF, Forster K, Taing LC, Cox JD, Macapinlac HA, Podoloff DA. Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1583-91. PMID 19396440 DOI: 10.1007/S00259-009-1135-8  0.474
2009 Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, Milas L, Wei Q. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3370-8. PMID 19380441 DOI: 10.1200/Jco.2008.20.6763  0.3
2009 Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng Y, Taddei PJ, Mirkovic D, Mohan R, Cox JD, Woo S. The risk of developing a second cancer after receiving craniospinal proton irradiation. Physics in Medicine and Biology. 54: 2277-91. PMID 19305036 DOI: 10.1088/0031-9155/54/8/002  0.415
2009 Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort. International Journal of Radiation Oncology, Biology, Physics. 74: 482-9. PMID 19289262 DOI: 10.1016/J.Ijrobp.2008.08.046  0.34
2009 Starkschall G, Britton K, McAleer MF, Jeter MD, Kaus MR, Bzdusek K, Mohan R, Cox JD. Potential Dosimetric Benefits of Four-Dimensional Radiation Treatment Planning International Journal of Radiation Oncology Biology Physics. 73: 1560-1565. PMID 19231098 DOI: 10.1016/J.Ijrobp.2008.12.024  0.331
2009 Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiation Oncology (London, England). 4: 5. PMID 19183471 DOI: 10.1186/1748-717X-4-5  0.483
2009 Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 91: 427-32. PMID 18937989 DOI: 10.1016/J.Radonc.2008.09.009  0.441
2009 Britton KR, Starkschall G, Liu H, Chang JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan R. Consequences of Anatomic Changes and Respiratory Motion on Radiation Dose Distributions in Conformal Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 73: 94-102. PMID 18929448 DOI: 10.1016/J.Ijrobp.2008.04.016  0.405
2009 Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 73: 119-27. PMID 18556142 DOI: 10.1016/J.Ijrobp.2008.03.069  0.415
2009 Arjomandy B, Sahoo N, Cox J, Lee A, Zhu XR, Gillin M. SU‐FF‐T‐105: Surface Doses Comparison for Spot Scanned and Passively Scattered Proton Therapy Beams Medical Physics. 36: 2544-2544. DOI: 10.1118/1.3181579  0.35
2009 Balter P, Starkschall G, Britton K, McAleer M, Mohan R, Cox J. Setup Margins for Gated Treatment of Lung Tumors International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1331  0.335
2009 Yuan X, Tucker S, Komaki R, Martel M, Zhuang Y, Cox J, Milas L, Mohan R, Liao Z. Association between Treatment-related Pneumonitis and the Overall Survival after Definitive Radiotherapy for Non–small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1079  0.441
2009 Wei X, Allen PK, Liao Z, Chang JY, Guerrero TM, Cox JD, Komaki R. Prophylactic Cranial Irradiation is More Important to Improve the Overall Survival among Patients with Limited Small–cell Lung Cancer Who Received One-Cycle Induction Chemotherapy and Had Complete Response to Therapy International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1055  0.489
2009 Chang J, Komaki R, Bucci M, Lu C, Wen H, DeGracia B, Gillin M, Mohan R, Cox J. Failure Patterns and Toxicity of Concurrent Proton Therapy and Chemotherapy for Stage III Non–small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 75: S446-S447. DOI: 10.1016/J.Ijrobp.2009.07.1021  0.448
2008 Komaki R, Allen PK, Wei X, Liao Z, Chang JY, Thames H, Glisson BS, Fossella FV, Oh Y, Ohnishi K, Cox JD. Prognostic factors identified in the long term survivors with limited small cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 7552. PMID 27947367 DOI: 10.1200/Jco.2008.26.15_Suppl.7552  0.428
2008 Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest. 134: 1349-1349. PMID 19059972 DOI: 10.1378/Chest.08-0655  0.388
2008 Rosen B, Starkschall G, Britton K, Mohan R, Cox JD. Utility of Four-Dimensional Computed Tomography for Analysis of Intrafractional and Interfractional Variation in Lung Volumes International Journal of Radiation Oncology Biology Physics. 72: 288-294. PMID 18722279 DOI: 10.1016/J.Ijrobp.2008.05.027  0.378
2008 Zhang X, Zhao KL, Guerrero TM, McGuire SE, Yaremko B, Komaki R, Cox JD, Hui Z, Li Y, Newhauser WD, Mohan R, Liao Z. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. International Journal of Radiation Oncology, Biology, Physics. 72: 278-87. PMID 18722278 DOI: 10.1016/J.Ijrobp.2008.05.014  0.432
2008 Ezhil M, Starkschall G, Mohan R, Cox J, Komaki R. Validation of a Model-Based Segmentation Approach to Propagating Normal Anatomic Regions of Interest Through the 10 Phases of Respiration International Journal of Radiation Oncology Biology Physics. 71: 900-906. PMID 18514782 DOI: 10.1016/J.Ijrobp.2008.02.025  0.308
2008 Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox JD, Chang JY. Effects of Interfractional Motion and Anatomic Changes on Proton Therapy Dose Distribution in Lung Cancer International Journal of Radiation Oncology Biology Physics. 72: 1385-1395. PMID 18486357 DOI: 10.1016/J.Ijrobp.2008.03.007  0.465
2008 Hirokawa Y, Yasui W, Komaki-Cox RU, Cox JD, Itou K, Tahara E. Radiation therapy for cancer. The fifteenth anniversary of Hiroshima Cancer Seminar Foundation, the Seventeenth International Symposium of Hiroshima Cancer Seminar, November 2007. Cancer Science. 99: 1287-91. PMID 18482054 DOI: 10.1111/J.1349-7006.2008.00805.X  0.416
2008 Kased N, Erasmus JJ, Komaki R, Cox JD. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 534-8. PMID 18449010 DOI: 10.1097/Jto.0B013E31816De265  0.45
2008 Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 277-82. PMID 18317071 DOI: 10.1097/Jto.0B013E3181653Ca6  0.447
2008 Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non-small cell lung cancer Journal of Thoracic Oncology. 3: 177-186. PMID 18303441 DOI: 10.1097/Jto.0B013E3181622Bdd  0.446
2008 Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. International Journal of Radiation Oncology, Biology, Physics. 70: 707-14. PMID 18191334 DOI: 10.1016/J.Ijrobp.2007.10.056  0.424
2008 Starkschall G, Britton K, McAleer MF, Jeter M, Kaus M, Bzdusek K, Mohan R, Cox J. SU‐GG‐T‐471: Potential Dosimetric Benefits of Four‐Dimensional Radiation Treatment Planning Medical Physics. 35: 2833-2833. DOI: 10.1118/1.2962219  0.341
2008 Tucker SL, Dong L, Michalski JM, Bosch W, Winter K, Mohan R, Kuban D, Cheung MR, Lee AK, Cox JD. Risk Factors for Grade 2+ Late Bladder Toxicity among Patients Treated on Protocol RTOG 94-06 International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.915  0.308
2008 Liengsawangwong R, Liu HH, Bucci MK, Allen PK, Khan M, Jeter M, O'Reilly M, Komaki R, Cox JD, Liao Z. The Pattern of Recurrence in Esophageal Cancer Patients Treated with Concurrent Chemoradiation with or without Surgery International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.632  0.363
2008 Liao ZX, Komaki R, Liu HH, Chen Y, Martel M, Wang S, Jin H, Mohan R, Cox JD, Tucker SL. Comparison of Toxicity Scoring Systems for Radiation Pneumonitis: Impact on Risk Estimates among Patients with Non-small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.409  0.441
2008 Zhang X, Li Y, Pan X, Mohan R, Komaki R, Cox JD, Chang JY. Reduced Normal Tissue Dose and Individualized Radical Radiotherapy by Intensity Modulated Proton Therapy Compared with Intensity Modulated Photon Therapy in NSCLC International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1828  0.375
2008 Ikushima H, Dong L, Allen P, Cox JD, Erasmus J, Mawlawi O, Mcaleer MF, Zhuang Y, Sasaki R, Komaki R. Predictive Value of 18F-fluorodeoxyglucose Uptake by Positron Emission Tomography for Non-small Cell Lung Cancer Patients Treated with Radical Radiotherapy Requires Consideration of Primary Tumor Size International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1814  0.393
2008 Wei X, Allen PK, Liao Z, Chang JY, Guerrero TM, Cox JD, Komaki R. One Cycle Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Associated with Improved Treatment Outcome in Patients with Limited Small-cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1382  0.446
2008 Liu H, Tucker S, Wei X, Jin H, Wang S, Martel M, Mohan R, Cox J, Komaki R, Liao Z. Incidence and Risk Factors for Acute Esophagitis in Inoperable Non-small Cell Lung Cancer Patients Treated with Definitive Radiation Therapy International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1378  0.479
2008 Chang JY, Balter P, Dong L, Bucci MK, Liao Z, Jeter MD, McAleer MF, Yang Q, Cox JD, Komaki R. Early Results of Stereotactic Body Radiation Therapy (SBRT) in Centrally/Superiorly Located Stage I or Isolated Recurrent NSCLC International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1377  0.406
2007 Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. International Journal of Radiation Oncology, Biology, Physics. 69: 1409-16. PMID 17904303 DOI: 10.1016/J.Ijrobp.2007.05.085  0.399
2007 Buchholz TA, McBride WH, Cox JD. Preparing for the future of radiation oncology. Journal of the American College of Radiology : Jacr. 4: 560-2. PMID 17660121 DOI: 10.1016/J.Jacr.2007.04.008  0.361
2007 Liao Z, Cox JD, Komaki R. Radiochemotherapy of esophageal cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 2: 553-68. PMID 17545853 DOI: 10.1097/01.JTO.0000275339.62831.5e  0.315
2007 Mason KA, Gillin MT, Mohan R, Cox JD. Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston. International Journal of Radiation Oncology, Biology, Physics. 68: 968-70. PMID 17512131 DOI: 10.1016/J.Ijrobp.2007.03.051  0.342
2007 Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 68: 1349-58. PMID 17446001 DOI: 10.1016/J.Ijrobp.2007.02.015  0.432
2007 Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR, Moran C, Allen PK, Komaki R. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. International Journal of Radiation Oncology, Biology, Physics. 68: 779-85. PMID 17418967 DOI: 10.1016/J.Ijrobp.2007.01.002  0.485
2007 Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, Chi M, Luo D, Pan T, Hunjan S, Starkschall G, Rosen I, Prado K, Liao Z, Chang J, ... ... Cox JD, et al. Assessing Respiration-Induced Tumor Motion and Internal Target Volume Using Four-Dimensional Computed Tomography for Radiotherapy of Lung Cancer International Journal of Radiation Oncology Biology Physics. 68: 531-540. PMID 17398035 DOI: 10.1016/J.Ijrobp.2006.12.066  0.342
2007 Yaremko BP, Guerrero TM, Noyola-Martinez J, Guerra R, Lege DG, Nguyen LT, Balter PA, Cox JD, Komaki R. Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance. International Journal of Radiation Oncology, Biology, Physics. 68: 562-71. PMID 17398028 DOI: 10.1016/J.Ijrobp.2007.01.044  0.428
2007 Britton KR, Starkschall G, Tucker SL, Pan T, Nelson C, Chang JY, Cox JD, Mohan R, Komaki R. Assessment of Gross Tumor Volume Regression and Motion Changes During Radiotherapy for Non-Small-Cell Lung Cancer as Measured by Four-Dimensional Computed Tomography International Journal of Radiation Oncology Biology Physics. 68: 1036-1046. PMID 17379442 DOI: 10.1016/J.Ijrobp.2007.01.021  0.347
2007 Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. International Journal of Radiation Oncology Biology Physics. 68: 94-102. PMID 17321067 DOI: 10.1016/J.Ijrobp.2006.12.031  0.502
2007 Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, Komaki R, Cox JD, Balter PA, Liu H, Zhu XR, Mohan R, Dong L. 4D Proton treatment planning strategy for mobile lung tumors. International Journal of Radiation Oncology, Biology, Physics. 67: 906-14. PMID 17293240 DOI: 10.1016/J.Ijrobp.2006.10.045  0.333
2007 Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. International Journal of Radiation Oncology, Biology, Physics. 67: 620-9. PMID 17236979 DOI: 10.1016/J.Ijrobp.2006.10.008  0.378
2007 Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3-5. PMID 17194900 DOI: 10.1200/Jco.2006.08.8195  0.569
2007 Britton K, Starkschall G, Liu H, Nelson CL, Chang JY, Kantor M, Cox J, Komaki R, Mohan R. SU‐FF‐J‐104: Impact of Anatomical Changes On Dose Distributions During Three‐Dimensional Radiotherapy (3D‐CRT) of Lung Cancer: Preliminary Study Using Multiple 4‐DCT Medical Physics. 34: 2392-2392. DOI: 10.1118/1.2760609  0.364
2007 Chang JY, Balter P, Liao Z, Bucci KM, McAleer MF, Yang Q, Dong L, Roth JA, Cox JD, Komaki R. PD5-2-6: Hypofractionated stereotactic body radiotherapy in patients with peripherally or centrally located medically inoperable stage I or isolated recurrent non-small cell lung cancer Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283432.89638.84  0.407
2007 Ohnishi K, Komaki R, Alen P, Cox J, Wei X, Liao Z. PD5-2-1: Effective local control of stage III non-small cell lung cancer (NSCLC) with accelerated radiotherapy for patients with unfavorable prognostic factors Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283427.59144.48  0.427
2007 Kang Y, Bucci MK, Liao Z, Liu HH, Tucker SL, Chang JY, Komaki R, Cox JD, Mohan R, Dong L. PD5-1-8: 4D CT imaging impacts lung volume definitions and dose-volume relationships in radiation treatment of non-small cell lung cancer Journal of Thoracic Oncology. 2: S474. DOI: 10.1097/01.JTO.0000283426.82014.6F  0.315
2007 Britton KR, Starkschall G, Liu H, Chang JY, Kantor M, Cox JD, Mohan R, Komaki R. PD5-1-3: What effects do anatomic changes during treatment have on target and normal tissue dosimetry parameters of lung cancer radiotherapy? A multiple 4DCT analysis Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283421.43897.A6  0.348
2007 Cox JD, Chang J, Liao Z, Bucci MK, McAleer MF, Wei X, Allen PK, Cai H, Gillin MT, Zhu R, Sahoo N, Woo SY, Komaki R. PD4-1-6: Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung cancer (NSCLS): Reduction in incidence and severity despite higher doses Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283376.48091.90  0.414
2007 Yom SS, Palmer M, Liao Z, Cox JD, Komaki R. PD6-1-6: Mid-course resimulation for small cell lung cancer patients receiving definitive chemoradiation: sparing of normal lung and esophagus without decrement in local control Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283328.75860.6C  0.4
2007 Cox JD. MTP20-01: Image guided radiation therapy: the path to protons Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283061.34074.00  0.345
2007 Bosch WR, Straube WL, Matthews JW, Michalski JM, Deasy JO, Young B, O'Meara E, Curran WJ, Cox JD, Purdy JA. A Survey of the ITC Volumetric Treatment Planning Data Archive Supporting RTOG Advanced Technology Clinical Trials International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.353  0.375
2007 Hui Z, Zhang X, Chang JY, Starkschall G, Komaki R, Cox JD, Mohan R. Effects of Inter-Fraction Anatomic Changes on Proton Therapy Dose Distributions in Lung Cancer International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.343  0.433
2007 Valicenti RK, Bae K, Michalski J, Cox J, Shipley W, Sandler H. Does Adjuvant Hormonal Therapy Improve Freedom From Biochemical Relapse in Prostate Cancer Patients Receiving Dose-Escalated Radiation Therapy? An Analysis of RTOG 94-06 International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.310  0.437
2007 Liao ZX, Cox JD, Liu HH, Komaki R, Tucker SL, Mohan R, Martel M, Wei X, Allen PK, Thames HD. Assessing the Impact of Technological Advancement on Outcome for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Concomitant Chemoradiotherapy International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.290  0.422
2007 Bucci MK, Dong L, Liao Z, Chang JY, Cox J, Komaki R, Gillin M, Mohan R. Comparison of Tumor Shrinkage in Proton and Photon Radiotherapy of Lung Cancer International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.2053  0.394
2007 Arjomandy B, Mohan R, Cox J. Evaluation of Residual Deviation in Patient Positioning and its Impact on Dose Distribution for Proton Radiotherapy International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.2047  0.34
2007 Ha C, Kong J, Dabaja B, Fayad L, Hess M, Kim E, Podoloff D, Cabanillas F, Cox J, Macapinlac H. How Often Does 18F-FDG PET Scan Change Management During Treatment of Hodgkin Lymphoma (HL)? International Journal of Radiation Oncology*Biology*Physics. 69: S544. DOI: 10.1016/J.Ijrobp.2007.07.1792  0.46
2007 Cox JD, Chang JY, Liao Z, Bucci MK, McAleer MF, Wei X, Allen PK, Cai H, Gillin M, Zhu XR. Acute Esophageal Reactions from Proton Beam Therapy and Concurrent Chemotherapy for Non-Small Cell Lung Cancer (NSCLC): Reduction in Incidence and Severity Despite Higher Doses International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1690  0.446
2007 Wei X, Komaki R, Allen PK, Garza VP, Liao Z, Chang JY, Guerrero TM, Bilton SD, Cox JD. Effects of Amifostine on Acute and Late Toxicity of Radiotherapy and Concurrent Chemotherapy for Local Advanced Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1674  0.447
2007 Lee AK, Kudchadker RJ, Amos RA, Johnson JL, Choi SL, Kuban DA, Cox JD, Mohan R, Gillin M, Dong L. Proton Therapy vs. IMRT for Prostate Cancer: A Dosimetric Comparison International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1422  0.344
2007 Jin H, Liu H, Tucker S, Liao Z, Wei X, Mohan R, Martel M, Cox J, Komaki R. Non-Smokers and Former Smokers at Increased Risk for Treatment Related Pneumonitis (TRP) in Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.109  0.413
2007 Cheung MR, Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Kuban D, Lee AK, Cox JD. Dose-Volume Analyses of Grade ≥ 2 Late Rectal Toxicity Among Patients Treated on Protocol RTOG 94-06 International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.018  0.381
2007 Chang JY, Zhang X, Cox JD. Comparison of Conformity Index In 3D-CRT, IMRT, and Proton Therapy in Lung Cancer: In Reply to Dr. Armstrong International Journal of Radiation Oncology Biology Physics. 68: 1272. DOI: 10.1016/J.Ijrobp.2007.02.038  0.421
2007 Lin Y, Liao Z, Komaki R, Allen P, Cox JD. Evaluation of conventional radiotherapy vs. conformal radiotherapy in the treatment of non-small-cell lung cancer after surgical resection The Chinese-German Journal of Clinical Oncology. 6: 514-518. DOI: 10.1007/S10330-007-0131-3  0.475
2006 O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 66: 883-91. PMID 17011461 DOI: 10.1016/J.Ijrobp.2006.06.044  0.351
2006 Wang SL, Liao Z, Liu H, Ajani JA, Swisher SG, Cox JD, Komaki R. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer World Journal of Gastroenterology. 12: 5501-5508. PMID 17006988 DOI: 10.3748/Wjg.V12.I34.5501  0.502
2006 Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R. Dose–volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery International Journal of Radiation Oncology Biology Physics. 66: 754-761. PMID 16965865 DOI: 10.1016/J.Ijrobp.2006.06.002  0.452
2006 Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R. Risk factors for acute esophagitis in non–small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy International Journal of Radiation Oncology Biology Physics. 66: 100-107. PMID 16839700 DOI: 10.1016/J.Ijrobp.2006.04.022  0.47
2006 Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non–small-cell lung cancer International Journal of Radiation Oncology Biology Physics. 65: 1087-1096. PMID 16682145 DOI: 10.1016/J.Ijrobp.2006.01.052  0.471
2006 Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher SG, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. International Journal of Radiation Oncology Biology Physics. 64: 692-699. PMID 16242257 DOI: 10.1016/J.Ijrobp.2005.08.002  0.441
2006 Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. International Journal of Radiation Oncology, Biology, Physics. 64: 700-8. PMID 16242255 DOI: 10.1016/J.Ijrobp.2005.08.008  0.307
2006 Rice DC, Liao Z, Vaporciyan A, Smythe W, Forster K, Liu H, Guerrero T, Komaki R, Cox J, Stevens C. QUANITY OF RADIATION RECEIVED BY THE CONTRALATERAL LUNG PREDICTS FATAL PULMONARY EVENTS AFTER INTENSITY MODULATED RADIATION THERAPY FOLLOWING EXTRAPLEURAL PNEUMONECTOMY FOR MESOTHELIOMA Chest. 130: 90S. DOI: 10.1378/chest.130.4_MeetingAbstracts.90S-c  0.301
2006 Zhang X, Chang JY, Liao Z, Komaki R, Cox J, Amos R, Arjomandy B, Kang Y, Wang X, Liu H, Dong L, Mohan R. TH‐C‐ValB‐06: Thoracic Proton Treatment Planning Strategies Based On the 4D CT Information Medical Physics. 33: 2269-2269. DOI: 10.1118/1.2241857  0.338
2006 O'daniel J, Dong L, Zhang L, Wang H, Tucker S, Kudchadker RJ, Crevoisier Rd, Lee A, Cheung R, Cox J, Kuban DA, Mohan R. WE‐E‐ValA‐02: Dosimetric Comparison of the No Action Level Alignment Protocol with Daily Alignment Techniques for Prostate Cancer Medical Physics. 33: 2253-2254. DOI: 10.1118/1.2241799  0.308
2006 Liengsawangwong R, Liao Z, Liu H, Tucker S, Wei X, Mohan R, Cox JD, Komaki R. 2487 : The Effect of Number of Treatment Fields per Fraction on the Risk of Treatment Related Pneumonitis of Patients With Non-Small Cell Lung Cancer Treated by Concurrent Chemoradiation International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.898  0.416
2006 Chang JY, Balter P, Liao Z, Melenda JD, Guerrero T, Borghero Y, Tutt TE, Roth JA, Cox JD, Komaki R. 2485: Preliminary Report of Image-Guided Hypofractionated Stereotactic Body Radiotherapy to Treat Patients With Medically Inoperable Stage I or Isolated Peripheral Lung Recurrent Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.896  0.438
2006 Klopp AH, Chang JY, Liu H, Balter PA, Macapinlac H, Komaki R, Cox JD. 2463: Intra-Thoracic Patterns of Failure for Non-Small Cell Lung Cancer (NSCLC) With PET/CT-Defined Target Delineation International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.874  0.371
2006 Huang EH, Liao Z, Cox JD, Guerrero T, Chang JY, Jeter M, Borghero Y, Wei X, Allen P, Komaki R. 2462: Induction Chemotherapy Improves Survival in Non-Squamous Unresectable Non-Small-Cell Lung Cancer Treated With Concurrent Chemoradiation International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.873  0.45
2006 Wei X, Liu HH, Wang S, Liao Z, Tucker SL, Mohan R, Cox JD, Komaki R. 2145: Risk Factors for Pericardial Effusion in Esophageal Cancer Treated With Definitive Chemoradiation Therapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.550  0.363
2006 Jeter MD, Liao Z, Riley BA, Frame RL, Liu HH, Arjomandy B, Bucci MK, Crawford C, Komaki R, Cox JD. 2117 : Significantly Reduced Lung and Heart Dose With Proton Radiotherapy Compared With IMRT for Esophageal Cancer International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.521  0.437
2006 Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Phan A, Mohan R, Cox JD, Komaki R. 2094 : Association Between Induction Chemotherapy and Increased Risk of Treatment Related Pneumonitis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.498  0.39
2006 Roach M, Moughan J, Movsas B, Konski A, Hanks G, Cox J, Watkins-Bruner D. 1127: Socio-Demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-Analysis International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.392  0.425
2006 Rohatgi PR, Chang JY, Spitz MR, Liu J, Lu C, Stewart D, Allen PK, Cox JD, Komaki R, Wu X. 1045 : p53 Polymorphisms Predict Poor Clinical Outcome in Non-Small-Cell Lung Cancer Patients Treated With Radiotherapy/Chemotherapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.310  0.445
2006 Yaremko BP, Guerrero TM, Noyola-Martinez J, Lege D, Nguyen L, Cox JD, Komaki R. 1039 : 4D CT Derived Ventilation IMRT Avoidance in Locally Advanced NSCLC International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.304  0.322
2006 Rice DC, Liao Z, Vaporciyan A, Smythe R, Forster K, Liu H, Guerrero T, Komaki R, Cox J, Stevens C. 111: V20 Predicts Fatal Pulmonary Toxicity After Extrapleural Pneumonectomy and Intensity Modulated Radiation Therapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.142  0.363
2005 Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu Cs, Mohan R, Cox JD, Komaki R. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) International Journal of Radiation Oncology Biology Physics. 66: 1399-1407. PMID 16997503 DOI: 10.1016/J.Ijrobp.2006.07.1337  0.479
2005 Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy International Journal of Radiation Oncology Biology Physics. 66: 108-116. PMID 16904517 DOI: 10.1016/J.Ijrobp.2006.04.015  0.414
2005 Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 77: 247-53. PMID 16298001 DOI: 10.1016/j.radonc.2005.10.017  0.346
2005 Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? International Journal of Radiation Oncology, Biology, Physics. 63: 362-72. PMID 16168831 DOI: 10.1016/J.Ijrobp.2005.01.060  0.388
2005 Ha CS, Cabanillas F, Lee MS, Tucker SL, McLaughlin P, Rodriguez MA, Younes A, Romaguera JE, Mesina OM, Cox JD. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. International Journal of Radiation Oncology, Biology, Physics. 63: 188-93. PMID 16111588 DOI: 10.1016/J.Ijrobp.2005.01.027  0.38
2005 Crevoisier Rd, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, Kuban DA. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. International Journal of Radiation Oncology Biology Physics. 62: 965-973. PMID 15989996 DOI: 10.1016/J.Ijrobp.2004.11.032  0.385
2005 Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosch W, Cox JD. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. International Journal of Radiation Oncology, Biology, Physics. 62: 706-13. PMID 15936549 DOI: 10.1016/J.Ijrobp.2004.11.028  0.384
2005 Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3342-8. PMID 15867233 DOI: 10.1158/1078-0432.Ccr-04-1741  0.479
2005 Chang JY, Komaki R, Sasaki R, Liao Z, Stevens CW, Lu C, Fossella FV, Allen PK, Cox JD, Spitz MR, Wu X. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 2894-8. PMID 15837739 DOI: 10.1158/1078-0432.Ccr-04-2176  0.472
2005 Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1136-43. PMID 15718309 DOI: 10.1200/Jco.2005.06.129  0.322
2005 Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R. Dose–response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy International Journal of Radiation Oncology Biology Physics. 61: 656-664. PMID 15708243 DOI: 10.1016/J.Ijrobp.2004.06.022  0.453
2005 Liu H, Wang X, Murshed H, Stevens C, Guerrero T, Balter PA, Prado K, Liao Z, Chang JY, Komaki R, Cox J, Mohan R. TU-E-T-6C-02: Clinical Implementation of IMRT for Lung Cancers Medical Physics. 32: 2102-2103. DOI: 10.1118/1.1999715  0.451
2005 Kang Y, Zhang X, Wang H, Chang J, Liao Z, Komaki R, Cox J, Mohan R, Rosen I, Prado K, Balter P, Liu H, Dong L. WE‐E‐J‐6C‐06: Proton Treatment Planning for Mobile Lung Tumors Medical Physics. 32: 2144-2144. DOI: 10.1118/1.1998594  0.339
2005 Zhang X, Dong L, Lee A, Cox J, Zhu X, Wang X, Kang Y, Liu H, Mohan R. SU-FF-T-344: Impact of Inter-Fractional Motion of the Anatomy On Prostate Proton Dose Medical Physics. 32: 2029-2030. DOI: 10.1118/1.1998073  0.323
2005 Ciangaru G, Tsunashima Y, Sakae T, Smith A, Mohan R, Starkschall G, Dong L, Komaki R, Akine Y, Cox J. SU‐FF‐T‐340: Effect of Marker Implants On Dose Distribution in Proton Therapy Medical Physics. 32: 2029-2029. DOI: 10.1118/1.1998069  0.309
2005 Liao Z, Komaki R, Milas L, Chen Y, Kies M, Chang J, Jeter M, Guerrero T, Blumenschein G, Cox J. P-959 A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC) Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)81452-7  0.466
2005 Chang J, Dong L, Mohan R, Liao Z, Cox J, Komaki R. PD-088 Image-guided proton radiotherapy for medically inoperable stage I non-small cell lung cancer Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80421-0  0.372
2005 Komaki R, Swann S, Byhardt R, Cox J, Scott C, Sause W. PD-074 Does response rate in the induction chemotherapy predictsurvival for locally advanced non-small cell lung cancer (LANSCLC)?: Secondary analysis of RTOG 8804/8808 Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80407-6  0.383
2005 Komaki R, Allen P, Roth J, Swisher S, Rice D, Fossella F, Herbst R, Oh Y, Munden R, Cox J. PD-044 Optimal treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with resectable SST Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80377-0  0.313
2005 Yom S, Liao Z, Liu H, Allen P, Chang J, Jeter M, Guerrero T, Stevens C, Cox J, Komaki R. O-152 Analysis of acute toxicity results of intensity modulated radiationtherapy (IMRT) in the treatment of non-small cell lung cancer (NSCLC) Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80286-7  0.399
2005 Fang CL, Komaki R, Allen P, Guerrero T, Mohan R, Cox J. O-142 Comparison of outcomes for patients with medically inoperablestage I non-small cell lung cancer treated with two-dimensional versus three-dimensional radiotherapy Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80276-4  0.407
2005 Rusch V, Albain K, Turrisi A, Swann S, Shepherd F, Chen Y, Livingston R, Darling G, Cox J, Sause W. O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309) Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80167-9  0.408
2005 Yom SS, Liao Z, Hu C, Wang S, Wei X, Tucker SL, Liu H, Allen PK, Mohan R, Cox JD, Komaki R. Preliminary Report of Radiation Pneumonitis (RP) in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Intensity Modulated Radiotherapy (IMRT) and Concurrent Chemotherapy (ConChT) International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.693  0.513
2005 Borghero Y, Guerrero T, Noyola-Martinez J, Cox J, Stevens C, Liao Z, Jeter M, Chang J, Sanders K, Komaki R. Interobserver Variability in Non-Small Cell Lung Cancer Target Delineation Among Thoracic Radiation Oncologists International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.691  0.433
2005 Chang JY, Zhang X, Wang X, Kang Y, Bilton S, Riley B, Liao Z, Jeter MD, Mohan R, Komaki R, Cox JD. Significantly Reduced Normal Tissue Dose with Proton Radiotherapy Compared with 3D-CRT or IMRT in Stage I or Stage III Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.686  0.451
2005 Zhu G, Lin Y, Liao Z, Allen PK, Stevens C, Chang J, Jeter M, Guerrero T, Roth J, Fossela F, Cox J, Komaki R. A Comparison of Outcomes in Patients with Pathological Stage I-IIIB Non-Small Cell Lung Cancer Treated with Postoperative Two- or Three-Dimensional Conformal Radiotherapy International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.674  0.462
2005 Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R. Analysis of Clinical and Dosimetric Factors Influencing Acute Esophagitis in Patients with Non-Small Cell Lung Cancer Treated with Concurrent Chemotherapy and Three Dimensional Conformal Radiotherapy International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.392  0.458
2005 Sulman EP, Chang JY, Liao Z, Guerrero TM, Jeter M, Stevens CW, Cox JD, Komaki R. Exclusion of Elective Nodal Irradiation Does Not Decrease Local Regional Control of Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.387  0.409
2005 Wang S, Liao Z, Vaporciyan A, Tucker S, Liu H, Wei X, Mohan R, Swisher S, Ajani J, Cox J, Komaki R. Dose-Volume Analyses of Postoperative Lung Complications in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy Followed by Surgery International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.281  0.38
2004 Komaki R, Spitz MR, Wu X, Chang JY, Allen PK, Lika M, Fossella FV, Stevens CW, Liao Z, Cox JD. Mutagen Sensitivity (MS) may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer (NSCLC) treated by chemoradiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 7232. PMID 28013872 DOI: 10.1200/Jco.2004.22.14_Suppl.7232  0.447
2004 Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. International Journal of Radiation Oncology, Biology, Physics. 60: 1484-93. PMID 15590179 DOI: 10.1016/J.Ijrobp.2004.05.056  0.449
2004 Arriagada R, Komaki R, Cox JD. Radiation dose escalation in non-small cell carcinoma of the lung. Seminars in Radiation Oncology. 14: 287-291. PMID 15558502 DOI: 10.1016/J.Semradonc.2004.07.003  0.432
2004 Jin J, Liao Z, Zhang Z, Ajani JA, Swisher SG, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan AA, Putnam J, Walsh GL, Smythe R, Roth JA, Yao JC, ... ... Cox JD, et al. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery International Journal of Radiation Oncology Biology Physics. 60: 427-436. PMID 15380576 DOI: 10.1016/J.Ijrobp.2004.03.033  0.428
2004 Chang EL, Shiu AS, Lii MF, Rhines LD, Mendel E, Mahajan A, Weinberg JS, Mathews LA, Brown BW, Maor MH, Cox JD. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. International Journal of Radiation Oncology, Biology, Physics. 59: 1288-94. PMID 15275711 DOI: 10.1016/J.Ijrobp.2004.04.025  0.375
2004 Brooks C, Starkschall G, Famiglietti R, Cox J, Frank S, Komaki R, Liao Z, Stevens C, Forster K. Heterogeneous planning for homogeneous protocols Medical Dosimetry. 29: 80-84. PMID 15191752 DOI: 10.1016/J.Meddos.2004.03.006  0.309
2004 Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Pisters KM, ... ... Cox JD, et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. International Journal of Radiation Oncology, Biology, Physics. 58: 1369-77. PMID 15050312 DOI: 10.1016/J.Ijrobp.2003.10.005  0.47
2004 Popat U, Hosing C, Saliba RM, Anderlini P, van Besien K, Przepiorka D, Khouri IF, Gajewski J, Claxton D, Giralt S, Rodriguez M, Romaguera J, Hagemeister F, Ha C, Cox J, et al. Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma. Bone Marrow Transplantation. 33: 1015-23. PMID 15048145 DOI: 10.1038/Sj.Bmt.1704483  0.322
2004 Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 58: 1268-79. PMID 15001272 DOI: 10.1016/J.Ijrobp.2003.09.085  0.439
2004 Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R, Change JY. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 58: 1258-67. PMID 15001271 DOI: 10.1016/J.Ijrobp.2003.09.086  0.464
2004 Michalski JM, Winter K, Purdy JA, Perez CA, Ryu JK, Parliament MB, Valicenti RK, Roach M, Sandler HM, Markoe AM, Cox JD. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV Presented at the 44th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, October 6-10, 2002 International Journal of Radiation Oncology Biology Physics. 58: 735-742. PMID 14967428 DOI: 10.1016/S0360-3016(03)01578-5  0.428
2004 Chronowski GM, Wilder RB, Levy LB, Atkinson EN, Ha CS, Hagemeister FB, Barista I, Rodriguez MA, Sarris AH, Hess MA, Cabanillas F, Cox JD. Second malignancies after chemotherapy and radiotherapy for Hodgkin disease. American Journal of Clinical Oncology. 27: 73-80. PMID 14758137 DOI: 10.1097/01.Coc.0000045853.73233.42  0.407
2004 Taylor NA, Liao Z, Cox JD, Stevens C, Roth JA, Walsh GL, Chang JY, Guerrero T, Jeter M, Putnam J, Fossella FV, Allen P, Komaki R. Equivalent outcome of patients with clinical Stage IIIA non–small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection International Journal of Radiation Oncology Biology Physics. 58: 204-212. PMID 14697440 DOI: 10.1016/S0360-3016(03)01575-X  0.452
2004 Chen Y, Liao Z, Zhang Z, Jing J, Ajani J, Swisher SG, Chang J, Guerrero T, Jeter M, Cox JD, Komaki R. Treatment outcome of irradiated esophageal cancer International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.07.098  0.347
2004 Chang JY, Wu X, Komaki R, Sasaki R, Allen P, Liao Z, Stevens CW, Lu C, Fossella FV, Cox JD, Spitz MR. Mutagen sensitivity predicts poor overall and disease specific survival in patients with stage III non-small cell lung cancer treated with chemo/radiotherapy International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.200  0.466
2004 Liao Z, Komaki R, Milas L, Chen Y, Chang JY, Jeter M, Guerrero T, Craig SW, Blumenschien G, Smith CM, Cox JD. Phase I clinical trial using selective cyclooxygenase-2 (COX-2) inhibitor celecoxib with concurrent thoracic irradiation in patients with poor prognosis non-small cell lung cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.063  0.421
2003 Cox JD, Ha CS, Lee HK, Dabaja BS, Wilder RB. Uncertainties in contemporary treatment of aggressive lymphomas. Rays. 28: 289-92. PMID 15018315  0.571
2003 Cox JD, Schechter NR, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L. Uncertainties in physical and biological targeting with radiation therapy. Rays. 28: 211-5. PMID 15018309  0.301
2003 Cox JD, Le Chevalier T, Arriagada R, Choy H, Curran WJ, Fukuoka M, Harper P, Komaki R, Le Pechoux C, Lievens Y, Rami-Porta R, Ready N, Sause W, Stuschke M, Thatcher N. Management of unresectable non-small cell carcinoma of the lung (NSCLC). Lung Cancer (Amsterdam, Netherlands). 42: S15-6. PMID 14708518 DOI: 10.1016/S0169-5002(03)00298-8  0.35
2003 Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. International Journal of Radiation Oncology, Biology, Physics. 57: 1317-22. PMID 14630268 DOI: 10.1016/S0360-3016(03)01373-7  0.431
2003 Ha CS, Kong JS, McLaughlin P, Tucker SL, Fayad LE, Hess MA, Wilder RB, Cabanillas F, Cox JD. Stage III follicular lymphoma: long-term follow-up and patterns of failure. International Journal of Radiation Oncology, Biology, Physics. 57: 748-54. PMID 14529780 DOI: 10.1016/S0360-3016(03)00641-2  0.44
2003 Valicenti RK, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J. RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? International Journal of Radiation Oncology Biology Physics. 57: 614-620. PMID 14529764 DOI: 10.1016/S0360-3016(03)00640-0  0.423
2003 Shiu AS, Chang EL, Ye JS, Lii M, Rhines LD, Mendel E, Weinberg J, Singh S, Maor MH, Mohan R, Cox JD. Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. International Journal of Radiation Oncology, Biology, Physics. 57: 605-13. PMID 14529763 DOI: 10.1016/S0360-3016(03)00792-2  0.336
2003 Dabaja BS, Ha CS, Wilder RB, Pro B, McLaughlin P, Cabanillas F, Cox JD. Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer Journal (Sudbury, Mass.). 9: 321-4. PMID 12967143 DOI: 10.1097/00130404-200307000-00015  0.481
2003 Ha CS, Kong JS, Tucker SL, McLaughlin P, Wilder RB, Hess MA, Cabanillas F, Cox JD. Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study. International Journal of Radiation Oncology, Biology, Physics. 57: 316-20. PMID 12957240 DOI: 10.1016/S0360-3016(03)00592-3  0.424
2003 Chakravarti A, Heydon K, Wu CL, Hammond E, Pollack A, Roach M, Wolkov H, Okunieff P, Cox J, Fontanesi J, Abrams R, Pilepich M, Shipley W. Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3328-34. PMID 12947069 DOI: 10.1200/Jco.2003.12.151  0.399
2003 Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Cancer. 98: 1021-8. PMID 12942571 DOI: 10.1002/cncr.11627  0.532
2003 Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. International Journal of Radiation Oncology, Biology, Physics. 57: 120-7. PMID 12909224 DOI: 10.1016/S0360-3016(03)00522-4  0.417
2003 Cox JD. History, protocols, and the team. International Journal of Radiation Oncology Biology Physics. 57: 1-2. PMID 12909205 DOI: 10.1016/S0360-3016(03)00758-2  0.392
2003 Liao Z, Milas L, Komaki R, Stevens C, Cox JD. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. American Journal of Clinical Oncology. 26: 85-91. PMID 12902863 DOI: 10.1097/01.Coc.0000074307.55019.29  0.406
2003 Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment planning for lung cancer: Traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription International Journal of Radiation Oncology Biology Physics. 56: 1308-1318. PMID 12873675 DOI: 10.1016/S0360-3016(03)00337-7  0.381
2003 Emami B, Mirkovic N, Scott C, Byhardt R, Graham MV, James Andras E, John M, Herskovic A, Urtasun R, Asbell SO, Perez CA, Cox J. The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data. Lung Cancer (Amsterdam, Netherlands). 41: 207-14. PMID 12871784 DOI: 10.1016/S0169-5002(03)00228-9  0.444
2003 Taylor NA, Liao Z, Stevens C, Walsh GL, Roth JA, Putnam J, Fossella FV, Allen P, Cox JD, Komaki R. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. International Journal of Radiation Oncology Biology Physics. 56: 616-625. PMID 12788166 DOI: 10.1016/S0360-3016(03)00063-4  0.428
2003 Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 2115-22. PMID 12775737 DOI: 10.1200/Jco.2003.07.111  0.447
2003 Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II International Journal of Radiation Oncology Biology Physics. 56: 192-198. PMID 12694838 DOI: 10.1016/S0360-3016(03)00072-5  0.456
2003 Gopal R, Starkschall G, Tucker SL, Cox JD, Liao Z, Hanus M, Kelly JF, Stevens CW, Komaki R. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer International Journal of Radiation Oncology Biology Physics. 56: 114-120. PMID 12694829 DOI: 10.1016/S0360-3016(03)00077-4  0.435
2003 Kirsner SM, Kudchadker RJ, Prado KL, Ha CS, Wilder RB, Cox JD. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation. International Journal of Radiation Oncology, Biology, Physics. 55: 1135-42. PMID 12605993 DOI: 10.1016/S0360-3016(02)04139-1  0.349
2003 Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 55: 36-43. PMID 12504034 DOI: 10.1016/S0360-3016(02)03915-9  0.421
2003 Bonnen MD, Liao Z, Craig SW, Cox JD, Helen L, Ritsuko K. Supine Positioning Reduces Lung Volumes Irradiated in Patients Treated for Esophageal Cancer The Cancer Journal. 9: 517. DOI: 10.1097/00130404-200311000-00116  0.339
2003 Chandra A, Liu H, Tucker SL, Liao Z, Stevens C, Chang J, Jeter M, O’Reilly M, Mohan R, Cox JD, Komaki R, Guerrero T. IMRT reduces lung irradiation in distal esophageal cancer over 3D CRT International Journal of Radiation Oncology Biology Physics. 57. DOI: 10.1016/S0360-3016(03)01307-5  0.419
2003 Forster KM, Stevens CW, Kitamura K, Chang JY, Cox JD, Guerrero TM, Jeter M, Liao Z, Starkschall G, Komaki R. Changes of tumor motion patterns during a course of radiation therapy for lung cancer International Journal of Radiation Oncology Biology Physics. 57. DOI: 10.1016/S0360-3016(03)01058-7  0.422
2003 Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Roth J, Putnam JB, Moran C, Cox JD. SUV by FDG-PET predicts outcome of non-small cell lung cancer International Journal of Radiation Oncology Biology Physics. 57. DOI: 10.1016/S0360-3016(03)00948-9  0.36
2002 Lee HK, Wilder RB, Jones D, Ha CS, Pro B, Rodriguez MA, Romaguera JE, Cabanillas F, Rodriguez J, Cox JD. Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas. Leukemia & Lymphoma. 43: 1769-75. PMID 12685830 DOI: 10.1080/1042819021000006277  0.418
2002 Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Cancer. 95: 2534-8. PMID 12467067 DOI: 10.1002/Cncr.10998  0.363
2002 Ryu JK, Winter K, Michalski JM, Purdy JA, Markoe AM, Earle JD, Perez CA, Roach M, Sandler HM, Pollack A, Cox JD. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). International Journal of Radiation Oncology, Biology, Physics. 54: 1036-46. PMID 12419429 DOI: 10.1016/S0360-3016(02)03006-7  0.443
2002 Schlembach PJ, Wilder RB, Jones D, Ha CS, Fayad LE, Younes A, Hagemeister F, Hess M, Cabanillas F, Cox JD. Radiotherapy alone for lymphocyte-predominant Hodgkin's disease. Cancer Journal (Sudbury, Mass.). 8: 377-83. PMID 12416895 DOI: 10.1097/00130404-200209000-00008  0.306
2002 Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer. 94: 2738-44. PMID 12173345 DOI: 10.1002/Cncr.10552  0.603
2002 Bubb RS, Komaki R, Hachiya T, Milas I, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion. International Journal of Radiation Oncology, Biology, Physics. 53: 1216-24. PMID 12128123 DOI: 10.1016/S0360-3016(02)02861-4  0.383
2002 Wilder RB, Rodriguez MA, Medeiros LJ, Tucker SL, Ha CS, Romaguera JE, Pro B, Hess MA, Cabanillas F, Cox JD. International prognostic index-based outcomes for diffuse large B-cell lymphomas. Cancer. 94: 3083-8. PMID 12115338 DOI: 10.1002/Cncr.10583  0.434
2002 Liao Z, Komaki R, Stevens C, Kelly J, Fossella F, Lee JS, Allen P, Cox JD. Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 53: 558-65. PMID 12062597 DOI: 10.1016/S0360-3016(02)02787-6  0.463
2002 Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament M, Pollack A, Markoe A, Harms WB, Sandler H, Cox JD. Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406. Seminars in Radiation Oncology. 12: 75-80. PMID 11917289 DOI: 10.1053/SRAO.2002.31378  0.328
2002 Komaki R, Lee JS, Kaplan B, Allen P, Kelly JF, Liao Z, Stevens CW, Fossella FV, Zinner R, Papadimitrakopoulou V, Khuri F, Glisson B, Pisters K, Kurie J, Herbst R, ... ... Cox JD, et al. Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results. Seminars in Radiation Oncology. 12: 46-9. PMID 11917284 DOI: 10.1053/Srao.2002.31363  0.446
2002 Wilder RB, Romaguera JE, Tucker SL, Ha CS, Hess MA, Cabanillas F, Cox JD. Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma. Cancer. 94: 601-5. PMID 11857290 DOI: 10.1002/Cncr.10260  0.435
2002 Jin J, Liao ZX, Zhang Z, Ajani JA, Swisher SG, Cox JD, Komaki R. Induction chemotherapy increased survival of patients with cancer of the esophagus treated with preoperative chemoradiation followed by surgery International Journal of Radiation Oncology Biology Physics. 54: 250. DOI: 10.1016/S0360-3016(02)03493-4  0.395
2002 Valicenti RK, Winter K, Cox JD, Sandler H, Bosch W, Michalski J. The effect on toxicity of induction hormonal therapy in prostate cancer patients receiving dose escalated 3D conformal radiation therapy on RTOG 94-06 International Journal of Radiation Oncology Biology Physics. 54: 133-134. DOI: 10.1016/S0360-3016(02)03287-X  0.431
2002 Michalski JM, Winter K, Perez CA, Purdy JA, Ryu J, Parliament M, Valicenti RK, Roach M, Sandler H, Markoe A, Cox JD. Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level IV International Journal of Radiation Oncology Biology Physics. 54: 107-108. DOI: 10.1016/S0360-3016(02)03242-X  0.414
2002 Komaki R, Lee JS, Milas L, Kaplan B, Allen P, Liao Z, Stevens CW, Fossella FV, Zinner R, Papadimitrakopoulou VA, Khuri F, Herbst RD, Kies MS, Blumenschein GR, Glisson BS, ... ... Cox JD, et al. Phase III trial of amifostine with chemoradiation for inoperable non-small cell lung cancer (NSCLC): does amifostine protect cancer cells International Journal of Radiation Oncology Biology Physics. 54: 105. DOI: 10.1016/S0360-3016(02)03237-6  0.4
2002 Taylor NA, Liao Z, Stevens CW, Putnam JB, Walsh G, Allen P, Cox JD, Komaki R. Concurrent chemo-radiation results in equivalent local and overall outcome as induction chemotherapy followed by surgery for clinical stage IIIA non-small cell lung cancer International Journal of Radiation Oncology Biology Physics. 54: 102. DOI: 10.1016/S0360-3016(02)03233-9  0.465
2001 Wilder RB, Jones D, Tucker SL, Fuller LM, Ha CS, McLaughlin P, Hess MA, Cabanillas F, Cox JD. Long-term results with radiotherapy for Stage I-II follicular lymphomas. International Journal of Radiation Oncology, Biology, Physics. 51: 1219-27. PMID 11728680 DOI: 10.1016/S0360-3016(01)01747-3  0.399
2001 Rosen II, Fischer TA, Antolak JA, Starkschall G, Travis EL, Tucker SL, Hogstrom KR, Cox JD, Komaki R. Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer Radiology. 221: 614-622. PMID 11719654 DOI: 10.1148/Radiol.2213992043  0.497
2001 Mason KA, Komaki R, Cox JD, Milas L. Biology-based combined-modality radiotherapy: Workshop report International Journal of Radiation Oncology Biology Physics. 50: 1079-1089. PMID 11429236 DOI: 10.1016/S0360-3016(01)01554-1  0.404
2001 Wilder RB, Rodriguez MA, Ha CS, Pro B, Hess MA, Cabanillas F, Cox JD. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma. Cancer. 91: 2440-6. PMID 11413536 DOI: 10.1002/1097-0142(20010615)91:12<2440::Aid-Cncr1279>3.0.Co;2-2  0.425
2001 Wilder RB, Rodriguez MA, Tucker SL, Ha CS, Hess MA, Cabanillas FF, Cox JD. Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. International Journal of Radiation Oncology, Biology, Physics. 50: 743-9. PMID 11395243 DOI: 10.1016/S0360-3016(01)01503-6  0.436
2001 Pelloski CE, Wilder RB, Ha CS, Hess MA, Cabanillas FF, Cox JD. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 59: 145-51. PMID 11325442 DOI: 10.1016/S0167-8140(01)00338-3  0.452
2001 Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Rodriguez MA, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas F. Primary cutaneous non-hodgkin's lymphoma of Ann Arbor stage I : Preferential cutaneous relapses but high cure rate with doxorubicin-based therapy Journal of Clinical Oncology. 19: 398-405. PMID 11208831 DOI: 10.1200/Jco.2001.19.2.398  0.404
2001 Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. International Journal of Radiation Oncology, Biology, Physics. 49: 17-22. PMID 11163493 DOI: 10.1016/S0360-3016(00)01383-3  0.429
2001 Bubb RS, Komaki R, Hachiya T, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, Hong WK. Ki-67, p53 and bcl-2 expression as prognostic indicators for patients with resectable brain metastasis from non-small cell lung cancer International Journal of Radiation Oncology Biology Physics. 51: 354-355. DOI: 10.1016/S0360-3016(01)02477-4  0.404
2001 Ryu J, Winter K, Michalski J, Purdy J, Markoe A, Earle J, Perez C, Roach M, Sandler H, Cox J, Pollack A. Preliminary report of toxicity following 3D Conformal Radiation Therapy (3DCRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy) International Journal of Radiation Oncology Biology Physics. 51: 136-137. DOI: 10.1016/S0360-3016(01)02072-7  0.399
2001 Stevens CW, Komaki R, Cox J. RESPONSE TO MACBETH AND PRICE CONCERNING OUR PAPER “Novel approaches to locally advanced non-small cell lung cancer” Radiotherapy and Oncology. 60: 226-227. DOI: 10.1016/S0167-8140(01)00353-X  0.343
2000 Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, Russell A, Komaki R, Lee JS. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. International Journal of Radiation Oncology Biology Physics. 48: 1475-1482. PMID 11121651 DOI: 10.1016/S0360-3016(00)00801-4  0.458
2000 Schlembach PJ, Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. International Journal of Radiation Oncology, Biology, Physics. 48: 1107-10. PMID 11072169 DOI: 10.1016/S0360-3016(00)00760-4  0.462
2000 Liao Z, Ha CS, McLaughlin P, Manning JT, Hess M, Cabanillas F, Cox JD. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression. International Journal of Radiation Oncology Biology Physics. 48: 399-403. PMID 10974453 DOI: 10.1016/S0360-3016(00)00628-3  0.414
2000 Komaki R, Roth JA, Walsh GL, Putnam JB, Vaporciyan A, Lee JS, Fossella FV, Chasen M, Delclos ME, Cox JD. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. International Journal of Radiation Oncology, Biology, Physics. 48: 347-54. PMID 10974447 DOI: 10.1016/S0360-3016(00)00736-7  0.411
2000 Nguyen LN, Ha CS, Hess M, Romaguera JE, Manning JT, Cabanillas F, Cox JD. The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum. International Journal of Radiation Oncology, Biology, Physics. 47: 1281-5. PMID 10889382 DOI: 10.1016/S0360-3016(00)00563-0  0.483
2000 Stevens CW, Lee JS, Cox J, Komaki R. Novel approaches to locally advanced unresectable non-small cell lung cancer. Radiotherapy and Oncology. 55: 11-18. PMID 10788683 DOI: 10.1016/S0167-8140(00)00163-8  0.48
2000 Dubey P, Wilson G, Mathur KK, Hagemeister FB, Fuller LM, Ha CS, Cox JD, Meistrich ML. Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP) International Journal of Radiation Oncology Biology Physics. 46: 609-617. PMID 10701740 DOI: 10.1016/S0360-3016(99)00338-7  0.462
2000 Michalski JM, Purdy JA, Winter K, Roach M, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. International Journal of Radiation Oncology, Biology, Physics. 46: 391-402. PMID 10661346 DOI: 10.1016/S0360-3016(99)00443-5  0.308
2000 Komaki R, Putnam JB, Walsh G, Lee JS, Cox JD. The management of superior sulcus tumors Seminars in Surgical Oncology. 18: 152-164. PMID 10657917 DOI: 10.1002/(Sici)1098-2388(200003)18:2<152::Aid-Ssu9>3.0.Co;2-H  0.44
2000 Schlembach PJ, Wilder RB, Tucker SL, Ha CS, Hess MA, Rodriguez MA, Cabanillas FF, Cox JD. Involved field radiotherapy after chop-based chemotherapy improves local control and freedom from progression in patients with bulky, clinical stage III-IV, intermediate grade of large-cell immunoblastic lymphomas International Journal of Radiation Oncology Biology Physics. 48: 331. DOI: 10.1016/S0360-3016(00)80466-6  0.389
2000 Ha CS, Tucker SL, Blanco AI, Wilder RB, Cabanillas F, Cox JD. Hematological recovery after central lymphatic irradiation (CLI) for stage I–III follicular lymphoma International Journal of Radiation Oncology Biology Physics. 48: 330-331. DOI: 10.1016/S0360-3016(00)80465-4  0.329
2000 Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament M, Pollack A, Markoe A, Harms WB, Sandler H, Cox JD. Update of toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 International Journal of Radiation Oncology Biology Physics. 48: 228. DOI: 10.1016/S0360-3016(00)80250-3  0.392
2000 Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras EJ. Age dramatically impacts on the quality-adjusted time without symptoms or toxicity (Q-Twist) in locally advanced non-Small cell lung cancer (LA-NSCLC)-a radiation therapy oncology group (RTOG) analysis International Journal of Radiation Oncology Biology Physics. 48: 157-158. DOI: 10.1016/S0360-3016(00)80109-1  0.439
2000 Komaki R, Seiferheld W, Curran W, Langer C, Lee J, Hauser S, Movasas B, Wasserman T, Russell A, Byhardt R, Sause W, Cox J. Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410) International Journal of Radiation Oncology*Biology*Physics. 48: 113. DOI: 10.1016/S0360-3016(00)80022-X  0.379
2000 Cox JD, Komaki R, Lee JS, Shin DM, Glisson B. Induction versus concurrent chemotherapy with radition therapy for unresectable non-small cell lung cancer (NSCLC) means competition between control of distant metastasis versus local/regional tumor Lung Cancer. 29: 160. DOI: 10.1016/S0169-5002(00)80541-3  0.453
2000 Curran W, Scott C, Langer C, Komaki R, Lee J, Hauser S, Movsas B, Wasserman T, Russell A, Byhardt R, Sause W, Cox J. Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 Lung Cancer. 29: 93. DOI: 10.1016/S0169-5002(00)80304-9  0.467
1999 Liao Z, Ha CS, Vlachaki MT, Hagemeister FB, Cabanillas F, Hess M, Tucker S, Cox JD. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure. International Journal of Radiation Oncology Biology Physics. 50: 971-977. PMID 11429225 DOI: 10.1016/S0360-3016(01)01525-5  0.4
1999 Ha CS, Tucker SL, Lee MS, McLaughlin P, Cabanillas F, Cox JD. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21). International Journal of Radiation Oncology Biology Physics. 49: 727-732. PMID 11172955 DOI: 10.1016/S0360-3016(00)01416-4  0.346
1999 Ha CS, Tucker SL, Blanco AI, Cabanillas F, Cox JD. Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study. International Journal of Radiation Oncology Biology Physics. 45: 1207-1212. PMID 10613314 DOI: 10.1016/S0360-3016(99)00300-4  0.439
1999 Machtay M, Seiferheld W, Komaki R, Cox JD, Sause WT, Byhardt RW. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience. International Journal of Radiation Oncology Biology Physics. 44: 847-853. PMID 10386642 DOI: 10.1016/S0360-3016(99)00120-0  0.472
1999 Oh YK, Ha CS, Samuels BI, Cabanillas F, Hess MA, Cox JD. Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies. Radiology. 210: 483-6. PMID 10207433 DOI: 10.1148/Radiology.210.2.R99Fe63483  0.394
1999 Ha CS, Cho MJ, Allen PK, Fuller LM, Cabanillas F, Cox JD. Primary non-hodgkin lymphoma of the small bowel Radiology. 211: 183-187. PMID 10189469 DOI: 10.1148/RADIOLOGY.211.1.R99AP30183  0.361
1999 Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, Parliament MB, Komaki R, Gaspar LEW. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials International Journal of Radiation Oncology Biology Physics. 43: 505-509. PMID 10078629 DOI: 10.1016/S0360-3016(98)00429-5  0.392
1999 Ha CS, Kavadi V, Dimopoulos MA, Hagemeister FB, Osborne BM, Fuller LM, Smith TL, Hess MA, McLaughlin PW, Cabanillas FF, Cox JD. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria. International Journal of Radiation Oncology, Biology, Physics. 43: 329-34. PMID 10030257 DOI: 10.1016/S0360-3016(98)00389-7  0.409
1998 Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies☆ International Journal of Radiation Oncology Biology Physics. 45: 1143-1149. PMID 10613306 DOI: 10.1016/S0360-3016(99)00325-9  0.496
1998 Lee JS, Komaki R, Fossella FV, Glisson BS, Hong WK, Cox JD. A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non–small-cell lung cancer: a 5-year follow-up report International Journal of Radiation Oncology Biology Physics. 42: 479-486. PMID 9806504 DOI: 10.1016/S0360-3016(98)00247-8  0.501
1998 Vlachaki MT, Ha CS, Hagemeister FB, Fuller LM, Rodriguez MA, Hess MA, Tucker SL, Cabanillas F, Cox JD. Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997. Radiology. 208: 739-47. PMID 9722855 DOI: 10.1148/Radiology.208.3.9722855  0.487
1998 Liebross RH, Ha CS, Cox JD, Weber DM, Delasalle K, Alexanian R. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy International Journal of Radiation Oncology Biology Physics. 41: 1063-1067. PMID 9719116 DOI: 10.1016/S0360-3016(98)00186-2  0.399
1998 Liao Z, Ha CS, Fuller LM, Hagemeister FB, Cabanillas F, Tucker SL, Hess MA, Cox JD. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors. International Journal of Radiation Oncology, Biology, Physics. 41: 1047-56. PMID 9719114 DOI: 10.1016/S0360-3016(98)00151-5  0.429
1998 Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, Shin HJC, Ki KH, Wimberly A, Pisters KMW, Schrump D, Gregurich MA, Cox JD, Roth JA, Hong WK. A multidisciplinary approach to therapy for unresectable malignant thymoma. Annals of Internal Medicine. 129: 100-104. PMID 9669967 DOI: 10.7326/0003-4819-129-2-199807150-00006  0.379
1998 Maor MH, North LB, Cabanillas FF, Ames AL, Hess MA, Cox JD. Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. International Journal of Radiation Oncology, Biology, Physics. 41: 647-50. PMID 9635715 DOI: 10.1016/S0360-3016(98)00083-2  0.349
1998 Geara FB, Komaki R, Tucker SL, Travis EL, Cox JD. Factors Influencing the Development of Lung Fibrosis after Chemoradiation for Small Cell Carcinoma of the Lung: Evidence for Inherent Interindividual Variation International Journal of Radiation Oncology Biology Physics. 41: 279-286. PMID 9607342 DOI: 10.1016/S0360-3016(97)00741-4  0.481
1998 Besien KV, Ha CS, Murphy S, McLaughlin P, Rodriguez A, Amin K, Forman A, Romaguera J, Hagemeister F, Younes A, Bachier C, Sarris A, Sobocinski KS, Cox JD, Cabanillas F. Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults With Intermediate-Grade and Immunoblastic Lymphoma Blood. 91: 1178-1184. DOI: 10.1182/Blood.V91.4.1178  0.373
1998 Komaki R, Thames HD, Colletier PJ, Smith CD, Fossella FV, Roth JA, Delclos ME, Glisson BS, Allen PK, Cox JD. Modality sequence and prophylactic cranial irradiation (PCI) are most significant in recursive partitioning analysis (RPA) of patients with limited small cell lung cancer (SCLC) treated with combined modality therapy International Journal of Radiation Oncology*Biology*Physics. 42: 338. DOI: 10.1016/S0360-3016(98)80528-2  0.373
1997 Cho MJ, Ha CS, Allen PK, Fuller LM, Cabanillas F, Cox JD. Primary non-hodgkin lymphoma of the large bowel Radiology. 205: 535-539. PMID 9356641 DOI: 10.1148/RADIOLOGY.205.2.9356641  0.319
1997 Komaki R, Scott C, Lee JS, Urtasun RC, Byhardt RW, Emami B, Andras EJ, Asbell SO, Rotman M, Cox JD. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06. American Journal of Clinical Oncology. 20: 435-440. PMID 9345325 DOI: 10.1097/00000421-199710000-00002  0.49
1997 Vlachaki MT, Ha CS, Hagemeister FB, Fuller LM, Rodriguez MA, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies. International Journal of Radiation Oncology, Biology, Physics. 39: 609-16. PMID 9336140 DOI: 10.1016/S0360-3016(97)00371-4  0.472
1997 Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 39: 537-44. PMID 9336129 DOI: 10.1016/S0360-3016(97)00365-9  0.465
1997 Sarris AH, Papadimitrakopoulou V, Dimopoulos MA, Smith T, Pugh W, Ha CS, McLaughlin P, Callender D, Cox J, Cabanillas F. Primary parotid lymphoma: The effect of International Prognostic Index on outcome Leukemia and Lymphoma. 26: 49-56. PMID 9250787 DOI: 10.3109/10428199709109157  0.425
1997 Perkins P, Lee JRJ, Kemp BL, Cox JD. Carcinoid tumors of the lung and family history of cancer Journal of Clinical Epidemiology. 50: 705-709. PMID 9250268 DOI: 10.1016/S0895-4356(97)00016-4  0.397
1997 Logsdon MD, Ha CS, Kavadi VS, Cabanillas F, Hess MA, Cox JD. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer. 80: 477-88. PMID 9241082 DOI: 10.1002/(Sici)1097-0142(19970801)80:3<477::Aid-Cncr16>3.0.Co;2-U  0.446
1997 Vlachaki MT, Hagemeister FB, Fuller LM, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression. International Journal of Radiation Oncology, Biology, Physics. 38: 593-9. PMID 9231684 DOI: 10.1016/S0360-3016(97)00036-9  0.434
1997 Scott C, Sause WT, Byhardt R, Marcial V, Pajak TF, Herskovic A, Cox JD. Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer. Lung Cancer. 17. PMID 9213303 DOI: 10.1016/S0169-5002(97)00640-5  0.501
1997 Dubey P, Ha CS, Besa PC, Fuller L, Cabanillas F, Murray J, Hess MA, Cox JD. Localized primary malignant lymphoma of bone. International Journal of Radiation Oncology, Biology, Physics. 37: 1087-93. PMID 9169817 DOI: 10.1016/S0360-3016(97)00106-5  0.453
1997 Roach M, Pajak TF, Byhardt R, Graham ML, Asbell SO, Russell AH, Fu KK, Urtasun RC, Herskovic AM, Cox JD. 2161 The impact of radiation dose and fractionation on the risk factor of radiation pneumonitis on four radiation therapy oncology group (RTOG) lung cancer trials International Journal of Radiation Oncology*Biology*Physics. 39: 321. DOI: 10.1016/S0360-3016(97)80928-5  0.349
1997 Colletier PJ, Komaki R, Schea RA, Allen P, Cox JD. 2150 Long term observations in combined modality therapy for limited stage small cell lung cancer International Journal of Radiation Oncology*Biology*Physics. 39: 315. DOI: 10.1016/S0360-3016(97)80916-9  0.312
1997 Lee JS, Komaki R, Fossella FV, Glisson BS, Cox JD, Hong WK. 530 Long-term survival outcome of patients with inoperable non-small cell lung cancer (NSCLC) following concurrent chemoradiation therapy with oral etoposide and cisplatin Lung Cancer. 18: 136. DOI: 10.1016/S0169-5002(97)89912-6  0.46
1997 Cox JD, Scott CB, Emami B, Russell AH, Fu K, Parliament M, Komaki R, Gaspar L. 491 Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials Lung Cancer. 18: 126. DOI: 10.1016/S0169-5002(97)89871-6  0.448
1997 Lee JS, Komaki R, Fossella FV, Glisson BS, Cox JD, Hong WK. 345 Long-term survival outcome of patients with inoperable non-small cell lung cancer (NSCLC) following concurrent chemoradiation therapy with oral etoposide and cisplatin Lung Cancer. 18: 88-89. DOI: 10.1016/S0169-5002(97)89726-7  0.46
1996 Wooden KK, Hogstrom KR, Blum P, Gastorf RJ, Cox JD. Whole-limb irradiation of the lower calf using a six-field electron technique Medical Dosimetry. 21: 211-218. PMID 8985926 DOI: 10.1016/S0958-3947(96)00129-X  0.324
1996 Seymour JF, McLaughlin P, Fuller LM, Hagemeister FB, Hess M, Swan F, Romaguera J, Rodriguez MA, Besa P, Cox J, Cabanillas F. High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma Annals of Oncology. 7: 157-163. PMID 8777172 DOI: 10.1093/OXFORDJOURNALS.ANNONC.A010543  0.323
1996 Fu KK, Cooper JS, Marcial VA, Laramore GE, Pajak TF, Jacobs J, Al-Sarraf M, Forastiere AA, Cox JD. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer International Journal of Radiation Oncology Biology Physics. 35: 425-438. PMID 8655364 DOI: 10.1016/S0360-3016(96)80003-4  0.45
1996 Emami B, Scott C, Byhardt R, Graham MV, Andras E, John M, Herskovic A, Urtasun RC, Asbell SO, Perez CA, Cox J. 102 The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis International Journal of Radiation Oncology*Biology*Physics. 36: 209. DOI: 10.1016/S0360-3016(97)85443-0  0.342
1995 Fu KK, Pajak TF, Marcial VA, Ortiz HG, Rotman M, Asbell SO, Coia LR, Vora NL, Byhardt R, Rubin P, Sorgen SD, Cox JD, Stetz J. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG 83-13 International Journal of Radiation Oncology, Biology, Physics. 32: 577-588. PMID 7790242 DOI: 10.1016/0360-3016(95)00080-I  0.44
1995 Touroutoglou N, Dimopoulos MA, Younes A, Hess M, Pugh W, Cox J, Cabanillas F, Sarris AH. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. Journal of Clinical Oncology. 13: 1361-1367. PMID 7751880 DOI: 10.1200/Jco.1995.13.6.1361  0.38
1995 Stroh EL, Besa PC, Cox JD, Fuller LM, Cabanillas FF. Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy Cancer. 75: 2392-2399. PMID 7712450 DOI: 10.1002/1097-0142(19950501)75:9<2392::AID-CNCR2820750932>3.0.CO;2-Y  0.34
1995 Besa PC, McLaughlin PW, Cox JD, Fuller LM. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma Cancer. 75: 2361-2367. PMID 7712449 DOI: 10.1002/1097-0142(19950501)75:9<2361::Aid-Cncr2820750928>3.0.Co;2-N  0.433
1995 Sause WT, Scott C, Taylor S, Johnson DH, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Dar AR, Cox JD. Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer Journal of the National Cancer Institute. 87: 198-205. PMID 7707407 DOI: 10.1093/Jnci/87.3.198  0.525
1995 Komaki R, Meyers CA, Shin DM, Garden AS, Byrne K, Nickens JA, Cox JD. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation International Journal of Radiation Oncology, Biology, Physics. 33: 179-182. PMID 7642416 DOI: 10.1016/0360-3016(95)00026-U  0.349
1995 Fuller LM, Krasin MJ, Velasquez WS, Allen PK, McLaughlin P, Rodriguez MA, Hagemeister FB, Swan F, Cabanillas F, Palmer JL, Cox JD. Significance of tumor size and radiation dose to local control in Stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation International Journal of Radiation Oncology, Biology, Physics. 31: 3-11. PMID 7527799 DOI: 10.1016/0360-3016(94)00343-J  0.455
1995 Schea RA, Perkins P, Allen PK, Komaki R, Cox JD. Limited-stage small-cell lung cancer: Patient survival after combined chemotherapy and radiation therapy with and without treatment protocols Radiology. 197: 859-862. PMID 7480770 DOI: 10.1148/Radiology.197.3.7480770  0.479
1994 Rock DB, Schultz CJ, Murray KJ, Wilson JF, Cox JD. Continuous split course irradiation for stage I and II Hodgkin's disease: 20 year experience at the Medical College of Wisconsin. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 30: 222-6. PMID 8209005 DOI: 10.1016/0167-8140(94)90461-8  0.475
1994 Cox JD. Brief history of comparative clinical trials in radiation oncology : perspectives from the silver anniversary of the radiation therapy oncology group Radiology. 192: 25-32. PMID 8208947 DOI: 10.1148/Radiology.192.1.8208947  0.379
1994 Bleehen NM, Ball D, Belani CP, Bishop J, Douillard JY, Cox JD, Johnson DH, Le Chevalier T, Saunders MI, Shaw E. Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma. Lung Cancer (Amsterdam, Netherlands). S19-23. PMID 8087510 DOI: 10.1016/0169-5002(94)91663-2  0.338
1994 Cox JD, Sause WT, Byhardt RW, Komaki R, Perez CA, Pajak TF. Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies Lung Cancer. 10. PMID 8087506 DOI: 10.1016/0169-5002(94)91678-0  0.483
1994 Cox J, Ball D, Belani C, Choi N, Gralla R, Halle J, Komaki R, Chevalier TL, Ohnoshi T, Quoix E, Ruffié P, Shaw E, Souhami R, Turrisi A. Dose intensity in lung cancer treatment Lung Cancer. 10. PMID 8087500 DOI: 10.1016/0169-5002(94)91661-6  0.424
1994 Mirimanoff RO, Rubin P, Cox JD, Gandara D, Grunenwald D, Hazuka M, Jassem J, Komaki R, Mattson K, McDonald S. Concomitant and alternating radiation therapy (RT) and chemotherapy (CT) for inoperable, M0, non-small cell lung cancers (NSCLC): a consensus report. Lung Cancer (Amsterdam, Netherlands). 11: S5-8. PMID 7704513 DOI: 10.1016/0169-5002(94)91857-0  0.36
1994 Green MR, Cox JD, Ardizzoni A, Arriagada R, Bureau G, Darwish S, Deneffe G, Fukuoka M, Joseph D, Komaki R, Mirimanoff RO, Mornex F, Palazzi M, Pastorino U, Pavy JJ, et al. Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report. Lung Cancer. 11. PMID 7704502 DOI: 10.1016/0169-5002(94)91859-7  0.403
1994 Preti A, Hagemeister FB, McLaughlin P, Swan F, Rodriguez A, Besa P, Cox JD, Allen PK, Cabanillas F. Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches Annals of Oncology. 5: 97-100. PMID 7515653 DOI: 10.1093/ANNONC/5.SUPPL_2.S97  0.33
1994 Rock DB, Schultz CJ, Murray KJ, Wilson JF, Cox JD. Continuous split course irradiation for stage I and II hodgkin's disease: 20 year experience at the medical college of Wisconsin Medical Dosimetry. 19: 190. DOI: 10.1016/0958-3947(94)90065-5  0.379
1993 Jacobs JP, Murray KJ, Schultz CJ, Wilson JF, Goswitz MS, Stevens CW, Cox JD. Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. Journal of Clinical Oncology. 11: 233-238. PMID 8426199 DOI: 10.1200/Jco.1993.11.2.233  0.478
1993 Byhardt RW, Martin L, Pajak TF, Shin KH, Emami B, Cox JD. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol. International Journal of Radiation Oncology, Biology, Physics. 27: 537-44. PMID 8226146 DOI: 10.1016/0360-3016(93)90377-8  0.383
1993 Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, Emami B, Roach M. Interruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trials International Journal of Radiation Oncology Biology Physics. 27: 493-498. PMID 8226140 DOI: 10.1016/0360-3016(93)90371-2  0.501
1993 Sause WT, Pajak T, Emami B, Byhardt R, Herskovic A, Cox JD. The radiation therapy oncology group experience altered fractionation in lung cancer Lung Cancer. 9: 229-238. DOI: 10.1016/0169-5002(93)90675-N  0.469
1993 Sause WT, Pajak T, Cox JD, Asbell SO, Perez C, Urtasun RC, Roach M. A Radiation Therapy Oncology Group experience: chemotherapy/radiation therapy of lung cancer Lung Cancer. 9: 61-68. DOI: 10.1016/0169-5002(93)90171-S  0.359
1992 Pollack A, Komaki R, Cox JD, Ro JY, Oswald MJ, Shin DM, Putnam JB. Thymoma: treatment and prognosis. International Journal of Radiation Oncology, Biology, Physics. 23: 1037-43. PMID 1639638 DOI: 10.1016/0360-3016(92)90911-Z  0.441
1992 Lawton CA, Cox JD, Glisch C, Murray KJ, Byhardt RW, Wilson JF. Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate? Cancer. 69: 2761-2766. PMID 1571906 DOI: 10.1002/1097-0142(19920601)69:11<2761::Aid-Cncr2820691122>3.0.Co;2-K  0.452
1992 Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, Selim HM, Byhardt RW, Rubin P, Ortiz HG, Martin L. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts: New evidence for accelerated proliferation from radiation therapy oncology group protocol 8313 Cancer. 69: 2744-2748. PMID 1571904 DOI: 10.1002/1097-0142(19920601)69:11<2744::Aid-Cncr2820691119>3.0.Co;2-U  0.446
1992 Pollack A, El-Naggar AK, Cox JD, Ro JY, Sahin AA, Komaki R. The prognostic significance of flow cytometric DNA analysis Cancer. 69: 1702-1709. PMID 1551054 DOI: 10.1002/1097-0142(19920401)69:7<1702::Aid-Cncr2820690710>3.0.Co;2-B  0.43
1992 Graham MV, Geitz LM, Byhardt R, Asbell S, Roach M, Urtasun RC, Curran WJ, Lattin P, Russell AH, Cox JD. Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer Journal of the National Cancer Institute. 84: 1731-1735. PMID 1331484 DOI: 10.1093/JNCI/84.22.1731  0.305
1992 Cox JD, Pajak TF, Asbell S, Russell AH, Pedersen J, Byhardt R, Emami B, Roach M. Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients International Journal of Radiation Oncology Biology Physics. 24: 193-194. DOI: 10.1016/0360-3016(92)90251-C  0.482
1992 Byhardt RW, Martin L, Pajak TF, Shin KH, Emami B, Cox JD. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 24: 192-193. DOI: 10.1016/0360-3016(92)90250-L  0.41
1991 Cox JD, Pajak TF, Marcial VA, Cola L, Mohiuddin M, Fu KK, Selim H, Rubin P, Ortiz H. Astro plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from radiation therapy oncology group protocol 8313 International Journal of Radiation Oncology, Biology, Physics. 20: 1191-1195. PMID 2045293 DOI: 10.1016/0360-3016(91)90227-U  0.316
1991 Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SRL, Rubin P. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706 International Journal of Radiation Oncology Biology Physics. 21: 935-939. PMID 1917622 DOI: 10.1016/0360-3016(91)90732-J  0.402
1991 Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Perez CA. N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. International Journal of Radiation Oncology Biology Physics. 20: 7-12. PMID 1847128 DOI: 10.1016/0360-3016(91)90131-M  0.456
1991 Cox JD, Pajak TF, Herskovic A, Urtasun R, Podolsky WJ, Seydel HG. Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08. American Journal of Clinical Oncology. 14: 280-4. PMID 1650526 DOI: 10.1097/00000421-199108000-00002  0.397
1991 Curran WJ, Cox JD, Azarnia N, Byhardt RW, Shin KH, Emani B, Phillips TL, Selim H, Herskovic A, Mohiuddin M, Ager PJ, Krisch R, Doggett RLS, Pajak TJ. Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy: A report of the Radiation Therapy Oncology Group protocol 83-11 Cancer. 68: 509-516. PMID 1648432 DOI: 10.1002/1097-0142(19910801)68:3<509::Aid-Cncr2820680311>3.0.Co;2-7  0.434
1991 Jacobs JP, Murray KJ, Wilson JF, Cox JD, Goswitz MS, Stevens CW, Schultz CJ. Central lymphatic irradiation for stage III nodular lymphoma: An update International Journal of Radiation Oncology Biology Physics. 21: 160. DOI: 10.1016/0360-3016(91)90515-6  0.332
1991 Komahi R, Pajak TF, Byhardt RW, Emami I, Asbell SO, Roach M, Pedersen JE, Curran WJ, Herskovic AM, Russell AH, Cox JD. Analysis of early and lats deaths on RTOG non-small cell lung carcinoma trials vs. CALGB 8433 International Journal of Radiation Oncology Biology Physics. 21: 137. DOI: 10.1016/0360-3016(91)90473-H  0.354
1991 Cox JD. The respective roles of radiation therapy and chemotherapy in non-small cell carcinoma of the lung with mediastinal but not distant metastasis (N2M0) Lung Cancer. 7: 65-69. DOI: 10.1016/0169-5002(91)90014-W  0.343
1990 Komaki R, Mountain CF, Holbert JM, Garden AS, Shallenberger R, Cox JD, Maor MH, Guinee VF, Samuels B. Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation. International Journal of Radiation Oncology, Biology, Physics. 19: 31-6. PMID 2380092 DOI: 10.1016/0360-3016(90)90130-C  0.488
1990 Cox JD, Pajak TF, Marcial VA, Hanks GE, Mohiuddin M, Fu KK, Byhardt RW, Rubin P. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: Preliminary report of radiation therapy oncology group protocol 83-13 International Journal of Radiation Oncology, Biology, Physics. 18: 515-521. PMID 2180866 DOI: 10.1016/0360-3016(90)90054-N  0.357
1990 Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. Journal of Clinical Oncology. 8: 1543-1555. PMID 2167952 DOI: 10.1200/Jco.1990.8.9.1543  0.51
1990 Komaki R, Cox JD, Kister SJ, Gump FE, Estabrook A. Stage I and II breast carcinoma: treatment with limited surgery and radiation therapy versus mastectomy. Radiology. 174: 255-7. PMID 2104676 DOI: 10.1148/RADIOLOGY.174.1.2104676  0.317
1990 Lai PP, Pilepich MV, Krall JM, Asbell SO, Hanks GE, Perez CA, Rubin P, Sause WT, Cox JD. The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: The radiation therapy oncology group 75-06 and 77-06 experience☆ International Journal of Radiation Oncology Biology Physics. 21: 925-933. PMID 1917621 DOI: 10.1016/0360-3016(91)90731-I  0.395
1989 Cox JD, Guse C, Asbell S, Rubin P, Sause WT. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 15: 1331-6. PMID 3058657 DOI: 10.1016/0360-3016(88)90228-3  0.382
1989 Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, Laramore GE, Marcial VA, Davis LW, Cox JD. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. International Journal of Radiation Oncology, Biology, Physics. 17: 449-56. PMID 2674073 DOI: 10.1016/0360-3016(89)90094-1  0.409
1989 Cox JD, Flynn DF, Pittman DD, Brady LW, del Regato JA. Radiation oncology: postgraduate medical education in the United States, 1988. International Journal of Radiation Oncology, Biology, Physics. 16: 1577-82. PMID 2656602 DOI: 10.1016/0360-3016(89)90965-6  0.557
1989 Cox JD, Azarnia N, Byhardt RW, Perez CA, Fu K, Spunberg JJ, Sause WT. Altered fractionation for non-small cell carcinoma of the lung. Rationale for the prospective trials of the Radiation Therapy Oncology Group Chest. 96. DOI: 10.1378/Chest.96.1_Supplement.68S  0.443
1989 Cox JD, Azarnia N, Byhardt RW, Shin KH, Perez CA. N2 (clinical) non-small cell carcinoma of the lung (NSCCL): Prospective trials of radiation therapy with total doses ≥ 60 GY by the radiation therapy oncology group (RTOG) International Journal of Radiation Oncology Biology Physics. 17: 156. DOI: 10.1016/0360-3016(89)90710-4  0.458
1988 Janjan NA, Wilson JF, Gillin M, Anderson T, Greenberg M, Schewe K, Cox JD. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease Cancer. 61: 252-254. PMID 3334958 DOI: 10.1002/1097-0142(19880115)61:2<252::Aid-Cncr2820610209>3.0.Co;2-G  0.329
1988 Cox JD. Time, dose, and fractionation in radiation therapy: an historical perspective. Frontiers of Radiation Therapy and Oncology. 22: 14-18. PMID 3280410 DOI: 10.1159/000415092  0.392
1988 Cox JD, Bauer M. Therapeutic ratio and fractionation in cancer of the lung. Frontiers of Radiation Therapy and Oncology. 22: 121-126. PMID 3280408 DOI: 10.1159/000415103  0.384
1988 Komaki R, Hansen R, Cox JD, Wilson JF. Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas. International Journal of Radiation Oncology Biology Physics. 15: 1447-1452. PMID 3198442 DOI: 10.1016/0360-3016(88)90242-8  0.514
1987 Toohill RJ, Anderson T, Byhardt RW, Cox JD, Duncavage JA, Grossman TW, Haas CD, Haas JS, Hartz AJ, Libnoch JA. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report. Archives of Otolaryngology--Head & Neck Surgery. 113: 758-61. PMID 3580158 DOI: 10.1001/Archotol.1987.01860070072019  0.337
1987 Toohill RJ, Duncavage JA, Grossmam TW, Malin TC, Teplin RW, Wilson JF, Byhardt RW, Haas JS, Cox JD, Anderson T. The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies. The Laryngoscope. 97: 407-12. PMID 3550340 DOI: 10.1288/00005537-198704000-00002  0.311
1987 Cox JD, Flynn DF, Pittman DD, del Regato JA. Postgraduate training in radiation oncology in the United States, 1986. International Journal of Radiation Oncology, Biology, Physics. 13: 1383-8. PMID 3305449 DOI: 10.1016/0360-3016(87)90234-3  0.559
1986 Komaki R, Cox JD, Hartz AJ, Wilson JF, Mattingly R. Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma. Cancer. 58: 873-879. PMID 3719554 DOI: 10.1002/1097-0142(19860815)58:4<873::Aid-Cncr2820580412>3.0.Co;2-U  0.469
1986 Cox JD, Byhardt RW, Wilson JF, Haas JS, Komaki R, Olson LE. Complications of radiation therapy and factors in their prevention. World Journal of Surgery. 10: 171-88. PMID 3518250 DOI: 10.1007/Bf01658134  0.385
1986 Cox JD, Barber-Derus S, Hartz AJ, Fischer M, Byhardt RW, Komaki R, Wilson JF, Greenberg M. Is adenocarcinoma/large cell carcinoma the most radiocurable type of cancer of the lung? International Journal of Radiation Oncology Biology Physics. 12: 1801-1805. PMID 3019958 DOI: 10.1016/0360-3016(86)90322-6  0.398
1986 Byhardt RW, Hartz A, Libnoch JA, Hansen R, Cox JD. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL). International Journal of Radiation Oncology, Biology, Physics. 12: 771-7. PMID 3011712 DOI: 10.1016/0360-3016(86)90035-0  0.315
1986 Byhardt RW, Cox JD, Libnoch JA, Komaki R, Holoye PY, Anderson T. Multiagent chemotherapy, prophylactic neuraxis irradiation, and consolidative irradiation for small cell carcinoma of the lung. American Journal of Clinical Oncology. 8: 504-11. PMID 3002168 DOI: 10.1097/00000421-198512000-00010  0.333
1986 Kun LE, Toohill RJ, Holoye PY, Duncavage JA, Byhardt RW, Ritch PS, Grossman TW, Hoffmann RG, Cox JD, Malin T. A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. International Journal of Radiation Oncology, Biology, Physics. 12: 173-8. PMID 2419292 DOI: 10.1016/0360-3016(86)90090-8  0.312
1986 Cox JD. Non-small cell lung cancer. Role of radiation therapy. Chest. 89. DOI: 10.1378/Chest.89.4_Supplement.284S  0.508
1985 Komaki R, Cox JD, Hartz A, Wilson JF, Greenberg M. Influence of preoperative irradiation on failures of endometrial carcinoma with high risk of lymph node metastasis. American Journal of Clinical Oncology. 7: 661-8. PMID 6528862 DOI: 10.1097/00000421-198412000-00013  0.325
1985 Komaki R, Cox JD, Hartz AJ, Byhardt RW, Perez-Tamayo C, Clowry L, Choi H, Wilson F, Lopes da Conceicao A, Rangala N. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. American Journal of Clinical Oncology. 8: 362-70. PMID 3933327 DOI: 10.1097/00000421-198510000-00005  0.357
1985 Gunter Seydel H, Diener-West M, Urtasun R, Podolsky WJ, Cox JD, Zinninger M, Francis ME. Hyperfractionation in the radiation therapy of unresectable non-oat cell carcinoma of the lung: Preliminary report of a RTOG pilot study International Journal of Radiation Oncology, Biology, Physics. 11: 1841-1847. PMID 3930443 DOI: 10.1016/0360-3016(85)90043-4  0.401
1985 Cox JD, Pittman DD, del Regato JA. Training in therapeutic radiology in the United States, 1984. International Journal of Radiation Oncology, Biology, Physics. 11: 1045-51. PMID 3886607 DOI: 10.1016/0360-3016(85)90130-0  0.517
1985 Holoye PY, Libnoch JA, Anderson T, Cox JD, Byhardt RW, Hoffmann RG. Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma. Cancer. 55: 1436-1445. PMID 2983855 DOI: 10.1002/1097-0142(19850401)55:7<1436::Aid-Cncr2820550703>3.0.Co;2-9  0.483
1985 Bleehen NM, Cox JD. Radiotherapy for lung cancer. International Journal of Radiation Oncology, Biology, Physics. 11: 1001-7. PMID 2580819 DOI: 10.1016/0360-3016(85)90123-3  0.406
1985 BYHARDT RW, KOMAKI R, COX JD, HOLOYE PY, LIBNOCH JA, ANDERSON T. 17. Multiagent Chemotherapy with Prophylactic Neuraxis Irradiation and Consolidative Irradiation for Small Cell Carcinoma of the Lung (SCCL) American Journal of Clinical Oncology. 8: 17. DOI: 10.1097/00000421-198502000-00017  0.301
1984 Choi H, Byhardt RW, Clowry LJ, Almagro UA, Remeniuk E, Holoye PY, Cox JD. The prognostic significance of histologic subtyping in small cell carcinoma of the lung. American Journal of Clinical Oncology. 7: 389-97. PMID 6095638 DOI: 10.1097/00000421-198410000-00001  0.347
1984 Perez CA, Brady LW, Cox J, Hanks G, Emami B, Asbell S, Pajak T. Randomized study to evaluate efficacy of levamisole in patients with unresectable non-oat cell carcinoma of the lung treated with radiation therapy International Journal of Radiation Oncology Biology Physics. 10: 97-98. DOI: 10.1016/0360-3016(84)90698-9  0.463
1983 Holoye PY, Libnoch JA, Byhardt RW, Cox JD. Integration of chemotherapy and radiation therapy for small cell carcinoma of the lung. International Journal of Radiation Oncology, Biology, Physics. 8: 1593-6. PMID 6292144 DOI: 10.1016/0360-3016(82)90622-8  0.387
1983 Byhardt RW, Cox JD, HOloye PY, Libnoch JA. The role of consolidation irradiation in combined modality therapy of small cell carcinoma of the lung. International Journal of Radiation Oncology, Biology, Physics. 8: 1271-6. PMID 6292141 DOI: 10.1016/0360-3016(82)90575-2  0.375
1983 Komaki R, Cox JD, Holoye PY, Byhardt RW. Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lung* American Journal of Clinical Oncology. 6: 515-521. DOI: 10.1097/00000421-198310000-00001  0.319
1982 Petrovich Z, Cox JD, Roswit B, MacKintosh R, Middleton R, Ohanian M, Rao Y, Byhardt RW, Paig C, del Regato JA. Advanced carcinoma of the nasopharynx. A clinical study of 274 patients. Radiology. 144: 905-8. PMID 6810406 DOI: 10.1148/radiology.144.4.6810406  0.621
1982 Cox JD, Holoye PY, Byhardt RW, Libnoch JA, Komaki R, Hansen RM, Kun LE, Anderson T. The role of thoracic and cranial irradiation for small cell carcinoma of the lung. International Journal of Radiation Oncology, Biology, Physics. 8: 191-6. PMID 6282790 DOI: 10.1016/0360-3016(82)90513-2  0.322
1982 Komaki R, Cox JD, Byhardt RW, Wilson JF, Conceicao ALd, Rangala N. Characteristics of Long-Term Survivors after Irradiation for Inoperable Carcinoma of the Lung American Journal of Clinical Oncology. 5: 137. DOI: 10.1097/00000421-198204000-00037  0.326
1981 Cox JD, Komaki R, Kun LE, Wilson JF, Greenberg M. Stage III nodular lymphoreticular tumors (non‐Hodgkin's lymphoma): Results of central lymphatic irradiation Cancer. 47: 2247-2252. PMID 7226120 DOI: 10.1002/1097-0142(19810501)47:9<2247::Aid-Cncr2820470924>3.0.Co;2-2  0.4
1981 Rangala N, Cox JD, Byhardt RW, Wilson JF, Greenberg M, Conceicao ALD. Local control and survival after external irradiation for adenocarcinoma of the prostate. International Journal of Radiation Oncology Biology Physics. 8: 1909-1914. PMID 6818193 DOI: 10.1016/0360-3016(82)90449-7  0.384
1981 Petrovich Z, Stanley K, Cox JD, Paig C. Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial. Cancer. 48: 1335-40. PMID 6268283 DOI: 10.1002/1097-0142(19810915)48:6<1335::AID-CNCR2820480614>3.0.CO;2-S  0.343
1981 Byhardt RW, Libnoch JA, Cox JD, Holoye PY, Kun L, Komaki R, Clowry L. Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small-cell carcinoma of the lung. Cancer. 47: 2239-46. PMID 6261937 DOI: 10.1002/1097-0142(19810501)47:9<2239::AID-CNCR2820470923>3.0.CO;2-0  0.354
1980 Wilson JF, Cox JD, Chahbazian CM, del Regato JA. Time dose relationships in endometrial adenocarcinoma: importance of the interval from external pelvic irradiation to surgery. International Journal of Radiation Oncology, Biology, Physics. 6: 597-600. PMID 7410135 DOI: 10.1016/0360-3016(80)90388-0  0.665
1980 Komaki R, Wilson JF, Cox JD, Kline RW. Carcinoma of the pancreas: Results of irradiation for unresectable lesions International Journal of Radiation Oncology Biology Physics. 6: 209-212. PMID 6967061 DOI: 10.1016/0360-3016(80)90039-5  0.426
1980 Wilson JF, Cox JD, Komaki R, Kun LE, Greenberg M. Preoperative radiation therapy of adenocarcinoma of the endometrium International Journal of Radiation Oncology Biology Physics. 6: 1433. DOI: 10.1016/0360-3016(80)90549-0  0.385
1979 Byhardt RW, Cox JD, Wilson JF, Libnoch J, Stein RS. Total body irradiation vs. chemotherapy as a systemic adjuvant for small cell carcinoma of the lung International Journal of Radiation Oncology Biology Physics. 5: 2043-2048. PMID 232501 DOI: 10.1016/0360-3016(79)90957-X  0.427
1978 Cox JD. Central lymphatic irradiation to low dose for advanced nodular lymphoreticular tumors (non-Hodgkin's lymphoma). Radiology. 126: 767-772. PMID 343169 DOI: 10.1148/126.3.767  0.413
1978 Cox JD, Byhardt RW, Wilson JF, Komaki R, Eisert DR, Greenberg M. Dose-time relationships and the local control of small cell carcinoma of the lung. Radiology. 128: 205-7. PMID 208099 DOI: 10.1148/128.1.205  0.333
1978 Cox JD, Komaki R, Wilson JF, Greenberg M. Locally advanced adenocarcinoma of the endometrium: Results of irradiation with and without subsequent hysterectomy International Journal of Radiation Oncology Biology Physics. 4: 177. DOI: 10.1016/0360-3016(78)90370-X  0.341
1977 Stoffel TJ, Cox JD. Hodgkin's disease stage I and II. A comparison between two different treatment policies Cancer. 40: 90-97. PMID 406982 DOI: 10.1002/1097-0142(197707)40:1<90::Aid-Cncr2820400117>3.0.Co;2-L  0.358
1977 Cox JD, Stoffel TJ. The significance of needle biopsy after irradiation for stage c adenocarcinoma of the prostate Cancer. 40: 156-160. PMID 406978 DOI: 10.1002/1097-0142(197707)40:1<156::AID-CNCR2820400126>3.0.CO;2-#  0.368
1977 Petrovich Z, Mietlowski W, Ohanian M, Cox JD. Clinical report on the treatment of locally advanced lung cancer Cancer. 40: 72-77. PMID 195709 DOI: 10.1002/1097-0142(197707)40:1<72::Aid-Cncr2820400114>3.0.Co;2-Q  0.524
1976 Eisert DR, Cox JD, Komaki R. Irradiation for bronchial carcinoma: reasons for failure. I. Analysis of local control as a function of dose, time, and fractionation. Cancer. 37: 2665-70. PMID 949684 DOI: 10.1002/1097-0142(197606)37:6<2665::AID-CNCR2820370614>3.0.CO;2-Y  0.344
1975 Cox JD. Primary malignant germinal tumors of the mediastinum. A study of 24 cases Cancer. 36: 1162-1168. PMID 1237349 DOI: 10.1002/1097-0142(197509)36:3<1162::Aid-Cncr2820360351>3.0.Co;2-0  0.347
1972 Cox JD, Laugier AJ, Gerard‐Marchant R. Apparently localized and regionally advanced malignant lymphoreticular tumors in the adult. Early course following irradiation. Cancer. 29: 1043-1051. PMID 4552810 DOI: 10.1002/1097-0142(197204)29:4<1043::Aid-Cncr2820290453>3.0.Co;2-8  0.302
1972 Cox JD, Gingerelli F, Ream NW, Maier JG. Total pulmonary irradiation for metastases from testicular carcinoma. Radiology. 105: 163-167. PMID 4262555 DOI: 10.1148/105.1.163  0.417
Show low-probability matches.